var title_f22_12_22720="Urticaria 4";
var content_f22_12_22720=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F77506&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F77506&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Urticaria",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 247px; height: 345px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Berg D, Worzala K. Atlas of Adult Physical Diagnosis. Philadelphia: Lippincott Williams &amp; Wilkins, 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22720=[""].join("\n");
var outline_f22_12_22720=null;
var title_f22_12_22721="Potters syndrome";
var content_f22_12_22721=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F72847&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F72847&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Facial appearance of a patient with Potter's syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 270px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical facial appearance observed in Potter's syndrome. Characteristic abnormalities include pseudoepicanthus, recessed chin, posteriorly rotated, flattened ears, and flattened nose.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22721=[""].join("\n");
var outline_f22_12_22721=null;
var title_f22_12_22722="Patient information: Concussion (The Basics)";
var content_f22_12_22722=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?8/47/8947\">",
"         Patient information: Closed head injury (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/45/40658\">",
"         Patient information: Head injury in children and adolescents (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?3/31/3570\">",
"         Patient information: Headache (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/59/41905\">",
"         Patient information: Vertigo (a type of dizziness) (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?40/31/41460\">",
"         Patient information: Dizziness and vertigo (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?13/44/14020\">",
"         Patient information: Head injury in children and adolescents (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?41/59/42931\">",
"         Patient information: Headache treatment in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Concussion (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/concussion-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H17925124\">",
"      <span class=\"h1\">",
"       What is a concussion?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A concussion is a mild brain injury that commonly causes confusion, memory loss, and a headache. Sometimes people pass out (lose consciousness) when they have a concussion, but not always.",
"     </p>",
"     <p>",
"      A concussion can happen after a person is hit on the head, face, or neck, or their head or upper body is shaken too hard. Sports injuries, car accidents, and falls are common causes of concussions.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17925139\">",
"      <span class=\"h1\">",
"       What are the symptoms of a concussion?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Symptoms that can happen minutes to hours after a concussion include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Memory loss &ndash; People sometimes forget what caused their injury, as well as what happened right before and after the injury.",
"       </li>",
"       <li>",
"        Confusion",
"       </li>",
"       <li>",
"        Headache",
"       </li>",
"       <li>",
"        Dizziness or trouble with balance",
"       </li>",
"       <li>",
"        Nausea or vomiting",
"       </li>",
"       <li>",
"        Feeling sleepy",
"       </li>",
"       <li>",
"        Acting cranky, strangely, or out of sorts (especially in young children)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Symptoms that can happen hours to days after a concussion include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Trouble walking or talking",
"       </li>",
"       <li>",
"        Memory problems or problems paying attention",
"       </li>",
"       <li>",
"        Trouble sleeping",
"       </li>",
"       <li>",
"        Mood or behavior changes",
"       </li>",
"       <li>",
"        Vision changes",
"       </li>",
"       <li>",
"        Being bothered by noise or light",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17925154\">",
"      <span class=\"h1\">",
"       Will I need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It depends on your injury and symptoms. To check if you have a concussion, your doctor will ask about your symptoms and do an exam. He or she will also ask you questions to check that you are thinking clearly.",
"     </p>",
"     <p>",
"      If your doctor suspects a serious injury, he or she might order an imaging test of the brain, such as a CT or MRI scan. These tests create pictures of the skull and inside of the brain.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17925169\">",
"      <span class=\"h1\">",
"       How is a concussion treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A concussion does not usually need treatment. Most concussions get better on their own, but it can take time. Some people&rsquo;s symptoms go away within minutes to hours. Other people have symptoms for weeks to months. When symptoms last a long time, doctors call it &ldquo;postconcussion syndrome.&rdquo;",
"     </p>",
"     <p>",
"      After your concussion, your doctor might recommend that someone watch you for 12 to 24 hours. This person should watch for symptoms. He or she should also wake you up every few hours (if you are sleeping) to make sure that you can be woken up.",
"     </p>",
"     <p>",
"      To help your brain heal after a concussion, you can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Rest your body &ndash; Make sure to get plenty of sleep. When you are awake, you should avoid heavy exercise or too much physical activity.",
"       </li>",
"       <li>",
"        Rest your brain &ndash; Avoid doing activities that need concentration or a lot of attention.",
"       </li>",
"       <li>",
"        Not drink alcohol for 2 days after the injury",
"       </li>",
"       <li>",
"        Take a pain-relieving medicine, if you have a headache &ndash; You can choose one with",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?19/35/20021?source=see_link\">",
"         acetaminophen",
"        </a>",
"        (sample brand name: Tylenol&reg;) or",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?14/17/14614?source=see_link\">",
"         ibuprofen",
"        </a>",
"        (sample brand names: Advil&reg;, Motrin&reg;).",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17925184\">",
"      <span class=\"h1\">",
"       When can I play sports or do my usual activities again?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Ask your doctor when you can play sports or do your usual activities again. It will depend on your injury and symptoms.",
"     </p>",
"     <p>",
"      It&rsquo;s important to let your brain heal completely after a concussion. Getting another concussion before your brain has healed can lead to serious brain problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17925199\">",
"      <span class=\"h1\">",
"       When should I call the doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Call the doctor or nurse if any of the following happen after a concussion:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        You vomit more than 3 times",
"       </li>",
"       <li>",
"        You have a severe headache, or a headache that gets worse",
"       </li>",
"       <li>",
"        You have a seizure",
"       </li>",
"       <li>",
"        You have trouble walking or talking",
"       </li>",
"       <li>",
"        Your vision changes",
"       </li>",
"       <li>",
"        You feel weak or numb in part of your body",
"       </li>",
"       <li>",
"        You lose control over your bladder or bowel",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If your doctor suggested that someone watch you after your concussion, this person should call the doctor or nurse if he or she:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Can&rsquo;t wake you up",
"       </li>",
"       <li>",
"        Sees any of the symptoms listed above",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17925214\">",
"      <span class=\"h1\">",
"       How can I prevent another concussion?",
"      </span>",
"      &nbsp;&mdash;&nbsp;To help prevent another concussion, you can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Wear a helmet when you ride a bike or motorcycle, or play certain sports",
"       </li>",
"       <li>",
"        Wear a seat belt when you drive or ride in a car",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If you have 1 concussion, it&rsquo;s very important to try to prevent future concussions. Having many concussions might cause long-term brain damage and affect your thinking.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H17925229\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/45/40658?source=see_link\">",
"       Patient information: Head injury in children and adolescents (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?8/47/8947?source=see_link\">",
"       Patient information: Closed head injury (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/31/3570?source=see_link\">",
"       Patient information: Headache (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/59/41905?source=see_link\">",
"       Patient information: Vertigo (a type of dizziness) (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/44/14020?source=see_link\">",
"       Patient information: Head injury in children and adolescents (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?41/59/42931?source=see_link\">",
"       Patient information: Headache treatment in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/31/41460?source=see_link\">",
"       Patient information: Dizziness and vertigo (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?22/12/22722?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16552 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-201.211.0.116-ECC848A2EF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22722=[""].join("\n");
var outline_f22_12_22722=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17925124\">",
"      What is a concussion?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17925139\">",
"      What are the symptoms of a concussion?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17925154\">",
"      Will I need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17925169\">",
"      How is a concussion treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17925184\">",
"      When can I play sports or do my usual activities again?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17925199\">",
"      When should I call the doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17925214\">",
"      How can I prevent another concussion?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17925229\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?8/47/8947?source=related_link\">",
"      Patient information: Closed head injury (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/31/41460?source=related_link\">",
"      Patient information: Dizziness and vertigo (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/44/14020?source=related_link\">",
"      Patient information: Head injury in children and adolescents (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/45/40658?source=related_link\">",
"      Patient information: Head injury in children and adolescents (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/31/3570?source=related_link\">",
"      Patient information: Headache (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/59/42931?source=related_link\">",
"      Patient information: Headache treatment in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/59/41905?source=related_link\">",
"      Patient information: Vertigo (a type of dizziness) (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_12_22723="Patient information: When your child has sickle cell disease (The Basics)";
var content_f22_12_22723=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/88642\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/5/36948\">",
"         Organs inside the abdomen",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?2/47/2802\">",
"         Patient information: Bone marrow transplant (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?33/40/34433\">",
"         Patient information: Priapism (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?6/21/6483\">",
"         Patient information: Reducing the costs of medicines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?23/4/23619\">",
"         Patient information: Vaccines for adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?27/22/28003\">",
"         Patient information: Vaccines for babies and children age 0 to 6 years (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/7/18547\">",
"         Patient information: Vaccines for children age 7 to 18 years (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?38/25/39318\">",
"         Patient information: Adult vaccines (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/4/34886\">",
"         Patient information: Bone marrow transplantation (stem cell transplantation) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/18/37156\">",
"         Patient information: Vaccines for children age 7 to 18 years (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?41/36/42566\">",
"         Patient information: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: When your child has sickle cell disease (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H35019089\">",
"      <span class=\"h1\">",
"       My child was diagnosed with sickle cell disease. What now?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your child is diagnosed with sickle cell disease, it&rsquo;s very important that he or she see a doctor who specializes in treating the disorder as soon as possible. Doctors who are experts in sickle cell disease are usually &ldquo;hematologists.&rdquo; When you find a sickle cell disease expert, talk to him or her about all the things you will need to do at home to take care of your child. Also, make sure your child keeps seeing the sickle cell disease expert. It&rsquo;s not enough to just see a regular doctor.",
"     </p>",
"     <p>",
"      Below is a list of the most important things you should know. The list is long and a little scary, but try not to get too nervous. Doctors have learned a lot about sickle cell disease in recent years. Today, children with sickle cell disease have fairly normal lives. To keep your child as healthy as possible, the key will be to know how to spot problems early and to know what to do about them.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H35019104\">",
"      <span class=\"h1\">",
"       Go to all of your child&rsquo;s check-ups",
"      </span>",
"      &nbsp;&mdash;&nbsp;Regular check-ups are important for all children, but they are really important for children with sickle cell disease. Make sure to keep all your child&rsquo;s appointments and always follow all of the doctor&rsquo;s instructions about treatments and tests. If you don&rsquo;t understand something, ask the doctor to explain it again, or ask a nurse. Also, make sure you know how to contact the sickle cell doctor or nurse in case of an emergency.",
"     </p>",
"     <p>",
"      During routine visits your child will be checked for problems that can happen because of sickle cell disease. He or she will also get vaccines that can prevent certain serious infections. These vaccines are very important, because infections in children with sickle cell disease are dangerous. Your child will need blood tests at most visits to check on the disease.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H35019213\">",
"      <span class=\"h1\">",
"       Infections and fevers are serious",
"      </span>",
"      &nbsp;&mdash;&nbsp;Any infection in a child with sickle cell disease can be serious. To prevent infection, your child might need to take antibiotics every day starting soon after birth until age 5.",
"     </p>",
"     <p>",
"      You should take your child to a doctor right away if he or she",
"      <strong>",
"       ever",
"      </strong>",
"      gets a fever. Usually, this means a temperature of more than 101.5&deg;F (38.5&deg;C). Talk to your doctor about a plan so that you know what to do when your child gets a fever. You should see a doctor or go to the emergency room even if the fever comes down quickly with or without medicines to bring down fever. Remember, fever equals doctor visit!",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H35019198\">",
"      <span class=\"h1\">",
"       Check your child&rsquo;s belly every day",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your child&rsquo;s doctor will teach you how to feel your child&rsquo;s belly every day to check if your child&rsquo;s spleen has gotten bigger. The spleen is an organ in the upper left part of the belly (",
"      <a class=\"graphic graphic_figure graphicRef61816 \" href=\"UTD.htm?36/5/36948\">",
"       figure 1",
"      </a>",
"      ). If it gets bigger, that&rsquo;s a sign that blood is getting trapped there. The belly check is most important in young children. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H35019183\">",
"      <span class=\"h1\">",
"       Learn to spot and treat pain",
"      </span>",
"      &nbsp;&mdash;&nbsp;Children with sickle cell disease can have bouts of pain. Learn to spot the signs of pain in your child. Your child&rsquo;s doctor will prescribe pain medicines and tell how you should treat pain at home. If those medicines do not do enough, take your child to the doctor or emergency room.",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        A baby who is in pain will not always cry. Instead, he or she might be less active or just lie still. Plus, the baby might have swelling in the top of the hands or feet.",
"       </li>",
"       <li>",
"        A school-aged child who is in pain might lose interest in his or her usual activities or try to ignore the pain. If the pain is not treated early, it can become hard to control. Teach your child to always tell you or another adult if he or she is having pain.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H35019168\">",
"      <span class=\"h1\">",
"       Coughing and breathing problems can be serious",
"      </span>",
"      &nbsp;&mdash;&nbsp;Children with sickle cell disease can get a dangerous condition called &ldquo;acute chest syndrome.&rdquo; It can cause symptoms like those of an infection in the lungs (called &ldquo;pneumonia&rdquo;). If your child ever has a bad cough or any wheezing or trouble breathing, take him or her to the doctor or emergency room right away.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H35019151\">",
"      <span class=\"h1\">",
"       Stroke is a risk",
"      </span>",
"      &nbsp;&mdash;&nbsp;Children with sickle cell disease are at risk of stroke. If your child ever has symptoms of a stroke, call the doctor who treats your child&rsquo;s sickle cell disease and take your child to the hospital. The symptoms of a stroke can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Being unable to move a side of the face, an arm, a leg, or both the arm and leg",
"       </li>",
"       <li>",
"        Trouble speaking or thinking clearly",
"       </li>",
"       <li>",
"        Seizure or severe headache",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Your child&rsquo;s doctor can do an ultrasound test called &ldquo;transcranial doppler&rdquo; to find out your child&rsquo;s risk of getting a stroke. This test is usually done every year starting when a child is 2 years old. If the test shows that your child has a high risk of stroke, your doctor will suggest treatments that can help prevent a stroke.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H35019134\">",
"      <span class=\"h1\">",
"       Long-lasting erections in boys can be a problem",
"      </span>",
"      &nbsp;&mdash;&nbsp;Boys with sickle cell disease can get a problem called &ldquo;priapism.&rdquo; Priapism is an erection that happens when blood gets trapped in the penis. It can be very painful and is not related to having sex or wanting to have sex. If your son gets painful erections, talk to his doctor. An erection that lasts more than 4 hours can cause long-term damage to the penis. If your son gets an erection that lasts 4 hours, take him to see the doctor or to an emergency room right away.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H35019119\">",
"      <span class=\"h1\">",
"       Sickle cell disease is passed on in families",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you are planning to have more children with the same partner, there is a high risk that your other children will have sickle cell disease, too. Talk to your doctor about these risks.",
"     </p>",
"     <p>",
"      There is also a chance that your child could pass the sickle cell disease on to his or her children. If your child wants to have children, he or she should talk to a doctor about the risks before having them. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H35019228\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?2/47/2802?source=see_link\">",
"       Patient information: Bone marrow transplant (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/22/28003?source=see_link\">",
"       Patient information: Vaccines for babies and children age 0 to 6 years (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/7/18547?source=see_link\">",
"       Patient information: Vaccines for children age 7 to 18 years (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/4/23619?source=see_link\">",
"       Patient information: Vaccines for adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=see_link\">",
"       Patient information: Reducing the costs of medicines (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/40/34433?source=see_link\">",
"       Patient information: Priapism (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?34/4/34886?source=see_link\">",
"       Patient information: Bone marrow transplantation (stem cell transplantation) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?41/36/42566?source=see_link\">",
"       Patient information: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/18/37156?source=see_link\">",
"       Patient information: Vaccines for children age 7 to 18 years (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/25/39318?source=see_link\">",
"       Patient information: Adult vaccines (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?22/12/22723?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 88642 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-201.65.114.212-1237D62C13-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22723=[""].join("\n");
var outline_f22_12_22723=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35019089\">",
"      My child was diagnosed with sickle cell disease. What now?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35019104\">",
"      Go to all of your child&rsquo;s check-ups",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35019213\">",
"      Infections and fevers are serious",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35019198\">",
"      Check your child&rsquo;s belly every day",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35019183\">",
"      Learn to spot and treat pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35019168\">",
"      Coughing and breathing problems can be serious",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35019151\">",
"      Stroke is a risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35019134\">",
"      Long-lasting erections in boys can be a problem",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35019119\">",
"      Sickle cell disease is passed on in families",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35019228\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/88642\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/5/36948\">",
"      Organs inside the abdomen",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/25/39318?source=related_link\">",
"      Patient information: Adult vaccines (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/47/2802?source=related_link\">",
"      Patient information: Bone marrow transplant (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?34/4/34886?source=related_link\">",
"      Patient information: Bone marrow transplantation (stem cell transplantation) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/40/34433?source=related_link\">",
"      Patient information: Priapism (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/4/23619?source=related_link\">",
"      Patient information: Vaccines for adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/22/28003?source=related_link\">",
"      Patient information: Vaccines for babies and children age 0 to 6 years (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/18/37156?source=related_link\">",
"      Patient information: Vaccines for children age 7 to 18 years (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/7/18547?source=related_link\">",
"      Patient information: Vaccines for children age 7 to 18 years (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/36/42566?source=related_link\">",
"      Patient information: Vaccines for infants and children age 0 to 6 years (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_12_22724="Dyshidrotic eczema mild 3";
var content_f22_12_22724=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83053&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83053&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Mild dyshidrotic eczema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mild forms of dyshidrotic eczema are clinically characterized by a small number of vesicles and mild erythema and desquamation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22724=[""].join("\n");
var outline_f22_12_22724=null;
var title_f22_12_22725="Calcaneus CT";
var content_f22_12_22725=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F54662&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F54662&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 565px\">",
"   <div class=\"ttl\">",
"    Coronal computed tomograph of the calcaneus and its anatomic correlate",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 545px; height: 327px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Anatomic correlation of anatomy with the coronal CT scan of the calcaneus. This is perhaps the most important view to assess the clinical reconstructability of the subtalar joint in displaced intra-articular fractures of the calcaneus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Jarvis JG, Moroz PJ. Fractures and Dislocations of the Foot. In: Rockwood and Wilkins' Fractures in Children, 6th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22725=[""].join("\n");
var outline_f22_12_22725=null;
var title_f22_12_22726="The decision to intubate";
var content_f22_12_22726=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   The decision to intubate",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/12/22726/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/12/22726/contributors\">",
"     Calvin A Brown, III, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/12/22726/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/12/22726/contributors\">",
"     Ron M Walls, MD, FRCPC, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/12/22726/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/12/22726/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/12/22726/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step in any resuscitation is the verification or establishment of a patent and protected airway. Emergent defibrillation is the sole, occasional exception to this principle. Without adequate oxygenation and ventilation, all other potentially life-saving maneuvers will fail. Most often, clinicians secure the airway of an unstable patient through placement of a cuffed endotracheal tube.",
"   </p>",
"   <p>",
"    The emergency clinician should be able to determine the need for a definitive airway quickly and confidently. Nevertheless, the standard resuscitation guides provide little more than brief, generalized statements about when to intubate [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22726/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review discusses how to determine the need for intubation and provides a simple decision tool that is applicable to virtually all emergency patients regardless of age and presenting condition. Discussions of other aspects of airway management are found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=see_link\">",
"     \"Emergent endotracheal intubation in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/51/18228?source=see_link\">",
"     \"The failed airway in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DECIDING TO INTUBATE: FOUR QUESTION ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emergency clinicians must often perform tracheal intubation under stressful conditions. Skillful execution of tracheal intubation requires a good understanding of several methods of intubation, how to identify the potentially difficult intubation, the drugs best suited for airway management in different clinical scenarios, and management of the difficult or failed airway. Deficiency in any of these areas reduces the likelihood of a good patient outcome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=see_link\">",
"     \"Rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=see_link\">",
"     \"Emergent endotracheal intubation in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/51/18228?source=see_link\">",
"     \"The failed airway in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Even knowledgeable emergency clinicians, however, can contribute to patient morbidity and mortality by waiting too long to intubate. Inappropriate delays in airway management can convert a relatively controlled opportunity to secure the airway into a \"crash\" airway scenario, eliminating the opportunity for a well-planned, methodical approach. As examples, clinicians should not postpone intubation until the patient with anaphylaxis develops stridor or wait for worsening of hoarseness in the patient with smoke inhalation.",
"   </p>",
"   <p>",
"    The decision to intubate can be obvious and require little deliberation, as with the comatose head-injured patient, who requires immediate intubation, or conversely the patient in moderate respiratory distress from heart failure who is rapidly improving with treatment and is unlikely to need invasive airway management. Between these extremes lies a range of airway management scenarios in which the need for tracheal intubation may be unclear. When facing such scenarios, the emergency clinician considers the patient's respiratory status, the pathologic process and likelihood of deterioration, patient age, comorbidities, and available resources.",
"   </p>",
"   <p>",
"    Whenever possible and particularly with patients suffering from terminal disease, the clinician should try to determine the patient's wishes regarding resuscitation (eg, intubation) either by asking the patient directly (assuming the patient retains capacity) or inquiring about an advanced directive (eg, \"Do not resuscitate\" order). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44024?source=see_link\">",
"     \"Ethical issues near the end of life\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In cases where the need for a definitive airway is not immediately clear, a simple assessment consisting of three basic questions can distinguish patients requiring intubation from those who can be observed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22726/abstract/4\">",
"     4",
"    </a>",
"    ]. An affirmative answer to any of the following questions identifies the need for intubation in nearly all emergency scenarios (",
"    <a class=\"graphic graphic_algorithm graphicRef68216 \" href=\"UTD.htm?17/23/17790\">",
"     algorithm 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Is there failure of airway maintenance or protection?",
"     </li>",
"     <li>",
"      Is there failure of oxygenation or ventilation?",
"     </li>",
"     <li>",
"      Is there an anticipated need for intubation (ie, what is the expected clinical course)?",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     IS THERE FAILURE OF AIRWAY MAINTENANCE OR PROTECTION?",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patient who can phonate clearly and answer questions appropriately demonstrates airway patency, adequate ventilation, vocal cord function, and cerebral perfusion with oxygenated blood. The level of alertness needed to maintain airway tone is the same required to maintain brisk protective reflexes to prevent aspiration of oral and gastric fluids. Aspiration of gastric contents can cause pneumonitis and result in prolonged mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22726/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The loss of protective airway reflexes mandates tracheal intubation. Traditional teaching promoted the presence of a gag reflex as evidence that protective reflexes were intact and aspiration would not occur. This is misleading and unfounded. The gag mechanism does not contribute to laryngeal closure and airway protection, and has little correlation with the Glasgow Coma Scale (GCS) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22726/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Furthermore a sizable segment of the normal adult population lacks a gag reflex [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22726/abstract/9\">",
"     9",
"    </a>",
"    ]. In one prospective observational study of 41 acutely poisoned patients requiring airway protection, clinicians found the absence of a gag reflex to be only 70 percent sensitive in detecting the need for a definitive airway, while the presence of a GCS of 8 or less was a better overall indicator of the need for intubation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22726/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The ability to swallow secretions is a more reliable sign of the patient's capacity for airway protection than the gag reflex. While this concept has not been subjected to rigorous scientific evaluation, swallowing represents a higher level of neurologic complexity and more accurately represents a patient's ability to protect against aspiration. A patient with pooling secretions, unable to swallow, requires intubation.",
"   </p>",
"   <p>",
"    Pulmonary gas exchange requires an unobstructed oropharyngeal inlet, which is maintained in awake patients by the upper airway musculature. An obstructed oropharynx makes any attempt to supply supplemental oxygen or assist ventilation difficult.",
"   </p>",
"   <p>",
"    Basic airway maneuvers, such as repositioning the patient's head with a jaw-thrust or chin-lift, or placement of oropharyngeal and nasopharyngeal airways can bypass flaccid, redundant upper airway tissue and provide an unobstructed passageway to the laryngeal inlet and trachea. In general, patients who require an oral or nasopharyngeal device and tolerate its placement need intubation for airway protection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link\">",
"     \"Basic airway management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     IS THERE FAILURE OF OXYGENATION?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Human tissues depend on oxygen for cellular respiration. While anaerobic metabolism can maintain function for a short time in tissues such as skeletal muscle, most specialized tissues, especially neuronal tissue, depend on oxygen and will sustain irreversible damage within a few minutes without an adequate supply of oxygenated blood. The inability to oxygenate poses an immediate life threat and, with rare exceptions, mandates intubation.",
"   </p>",
"   <p>",
"    Advances in noninvasive positive pressure ventilation (NIPPV) have modified our approach to hypoxic patients with acute cardiogenic pulmonary edema (HF) and acute exacerbations of chronic obstructive pulmonary disease (COPD). Often NIPPV enables these patients to avoid intubation during the acute phase of their illness, but its use is limited to alert patients capable of protecting their airway against aspiration. The role of NIPPV in patients with other causes of acute respiratory distress remains unclear. NIPPV is contraindicated in patients with severe respiratory distress requiring immediate tracheal intubation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1850?source=see_link\">",
"     \"Noninvasive positive pressure ventilation in acute respiratory failure in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinicians assess the patient's oxygenation using clinical criteria and oxygen saturation measurements. Clinically, hypoxic patients act restless and agitated, and with severe hypoxemia can appear cyanotic. As hypoxia worsens, confusion, somnolence, and obtundation occur. Pulse oximetry provides an accurate estimate of arterial oxygen tension, but can be unreliable when peripheral perfusion is compromised [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22726/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=see_link\">",
"     \"Pulse oximetry\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=see_link\">",
"     \"Oxygenation and mechanisms of hypoxemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinicians should not rely on arterial blood gases (ABG) in the emergent setting to determine the immediate need for intubation. ABGs provide little information not already apparent from clinical presentation and pulse oximetry, and can be misleading. As an example, an \"unimpressive\" ABG in a severe asthmatic may persuade the emergency clinician to postpone intubation when clinically the patient is failing. Waiting in such circumstances can be disastrous, creating a crash airway when the patient suddenly becomes apneic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     IS THERE FAILURE OF VENTILATION?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Removal of carbon dioxide (CO2), the major waste product of cellular metabolism, depends on proper lung function and ventilation. Impaired ventilation from airway obstruction, muscular weakness, or drug-induced hypopnea results in impaired CO2 elimination.",
"   </p>",
"   <p>",
"    Clinicians can generally gauge a patient's ventilations by observing respirations and mental status. Capnography provides a simple means of continuously measuring end-tidal CO2 to assess the adequacy of ventilation, when this is not clear, or to monitor the response to treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/18/44328?source=see_link\">",
"     \"Carbon dioxide monitoring (capnography)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with chronic ventilatory failure (eg, chronic obstructive pulmonary disease, or COPD) can acclimate to the altered gas tensions of impaired ventilation if decompensation is gradual, but acute CO2 retention can lead to altered mental status and respiratory acidosis. Patients with inadequate ventilation require intubation, unless the cause is rapidly reversible (eg, opioid overdose). In select patients with acute exacerbations of COPD, the use of continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BLPAP) obviates tracheal intubation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22726/abstract/13-17\">",
"     13-17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1850?source=see_link\">",
"     \"Noninvasive positive pressure ventilation in acute respiratory failure in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite advances in noninvasive positive pressure ventilation (NIPPV), many patients, especially malnourished or dehydrated patients, fail trials of CPAP or BLPAP. Other patients present too ill for such measures to be effective, and intubation is needed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22726/abstract/18\">",
"     18",
"    </a>",
"    ]. Continual reevaluation of patients treated with CPAP or BLPAP is required to detect clinical deterioration and provide definitive airway management if needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     IS THERE AN ANTICIPATED NEED FOR INTUBATION?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Failure to maintain airway protection, oxygenation, and ventilation comprise straightforward criteria for intubation that encompass the majority of emergency airway cases. Some emergency patients may meet none of these criteria yet still require intubation.",
"   </p>",
"   <p>",
"    Often, acutely ill or injured patients initially appear awake and alert, speak clearly in full sentences, demonstrate adequate oxygen saturation, and appear not to require immediate airway management. Nevertheless, the natural progression of their disease would result in airway compromise or an inability to maintain oxygenation if the emergency clinician were not to intervene. By pursuing early, aggressive airway management, emergency clinicians avoid \"crash\" airway situations, when equipment, medications, and personnel may not be ready. It is preferable to err on the side of caution and place a definitive airway if the potential for airway compromise exists.",
"   </p>",
"   <p>",
"    As an example, an elderly patient with pneumonia and severe sepsis who is somnolent but arousable, with adequate oxygen saturation on supplemental oxygen, may not initially meet any of the three criteria described above for tracheal intubation. Nevertheless, the patient's anticipated clinical course is a decline in respiratory function. During the resuscitative phase of sepsis management, the patient will receive intravenous isotonic fluids, antibiotics, and possibly blood products. This fluid load coupled with a diffuse capillary leak syndrome will increase pulmonary interstitial edema and likely lead to respiratory failure with worsening hypoxemia and acidemia.",
"   </p>",
"   <p>",
"    As another example, the burn victim with evidence of significant smoke inhalation likely requires immediate intubation (or at least direct or fiberoptic examination of the upper airway structures and glottis) because the projected clinical course is complete airway obstruction, although initially the patient may manifest no sign of airway compromise.",
"   </p>",
"   <p>",
"    Patients with potential for respiratory decompensation who must be transported out of the emergency department often require intubation. Regardless of whether transport is to the radiology department or to another institution for specialized care, it is better to secure the airway preemptively than to face a crash airway in an unfavorable setting, such as a CT scanner or the back of an ambulance. For trauma patients, intubation may be indicated before transport if the likelihood of deterioration is high, based on mechanism, injuries discovered on primary and secondary surveys, and initial hemodynamics.",
"   </p>",
"   <p>",
"    No guidelines or algorithms exist for this aspect of airway management, and there is no way to anticipate every possible scenario in which preemptive intubation is needed. A careful clinical assessment, including pulse oximetry (and often capnography), vital signs, the patient's mental and respiratory status, the patient's comorbidities and response to the acute threat, and a knowledge of the natural history of the condition with which the patient presents all guide the need for preemptive intubation. If there is any significant concern that a patient's deterioration will ultimately threaten the airway or make intubation more difficult, early intubation is indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     APPROACH TO THE PATIENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the patient is not comatose or in extremis, emergency clinicians assess the patient by asking three questions:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Is there failure of airway maintenance or protection?",
"     </li>",
"     <li>",
"      Is there failure of oxygenation or ventilation?",
"     </li>",
"     <li>",
"      Is there an anticipated need for intubation (ie, what is the expected clinical course)?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The quickest test of airway patency and maintenance is to listen to the patient's speech. Clear, coherent speech is a good indication of a patent and protected airway, and a reassuring sign the airway is not in imminent danger.",
"   </p>",
"   <p>",
"    If the patient is unable to phonate or his speech sounds altered, the clinician performs a rapid investigation for upper airway obstruction. A jaw-thrust and chin-lift, with cervical spine immobilization if indicated, is the first maneuver, followed by inspection of the oropharynx for solid or liquid material that can be removed or suctioned. The neck is inspected and palpated for fixed or expanding masses, laryngeal fracture, and crepitus. Stridor is a foreboding sign indicating impending airway occlusion, and immediate intubation is required. If these maneuvers do not identify the problem and the patient remains unable to phonate and protect his airway, intubation is performed. As part of the airway examination, clinicians assess whether a difficult airway exists. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Assessment of oxygenation and ventilation status is predominantly clinical. Hypopnea, poor chest excursion, agitation or somnolence, and low oxygen saturation by pulse oximetry generally provide all the data required. Capnography can provide important information about ventilation, respiratory status, and response to treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=see_link\">",
"     \"Pulse oximetry\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/18/44328?source=see_link\">",
"     \"Carbon dioxide monitoring (capnography)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Overall patient condition may dictate intubation, even if no specific criteria are met. All potentially unstable patients requiring prolonged emergency department evaluation or transport to other facilities are candidates for early airway management. This anticipatory step provides safer patient care because it helps to reduce the likelihood of a chaotic crash intubation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When the need for intubation is unclear, emergency clinicians assess the patient by asking three questions. An affirmative answer to any of the following questions identifies the need for intubation in nearly all emergency scenarios:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Is there failure of airway maintenance or protection?",
"     </li>",
"     <li>",
"      Is there failure of oxygenation or ventilation?",
"     </li>",
"     <li>",
"      Is there an anticipated need for intubation (ie, what is the expected clinical course)? (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Deciding to intubate: four question assessment'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      An algorithm incorporating these questions is provided (",
"      <a class=\"graphic graphic_algorithm graphicRef68216 \" href=\"UTD.htm?17/23/17790\">",
"       algorithm 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The gag reflex has no role in determining the need for intubation or the patient's ability to protect their airway. The gag mechanism does not contribute to laryngeal closure and airway protection, and a sizable segment of the normal adult population lacks a gag reflex. The ability to sense and swallow secretions is a more reliable sign of the patient's capacity for airway protection than the gag reflex. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Is there failure of airway maintenance or protection?'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Noninvasive positive pressure ventilation (NIPPV) often enables patients with acute cardiogenic pulmonary edema (HF) and acute exacerbations of chronic obstructive pulmonary disease (COPD) to avoid intubation acutely, but its use is limited to alert patients capable of protecting their airway against aspiration. NIPPV is contraindicated in patients with severe respiratory distress requiring immediate tracheal intubation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1850?source=see_link\">",
"       \"Noninvasive positive pressure ventilation in acute respiratory failure in adults\"",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H4\">",
"       'Is there failure of oxygenation?'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Is there failure of ventilation?'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinicians should not rely on arterial blood gases (ABG) in the emergent setting to determine the immediate need for intubation. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Is there failure of oxygenation?'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Despite the absence of overt signs of respiratory distress, some patients need early intubation, because of their anticipated clinical course, particularly the possibility of respiratory decompensation when outside the ED, or the progression of upper airway compromise. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Is there an anticipated need for intubation?'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Advanced Trauma Life Support for Doctors, 7th, American College of Surgeons, 2004. p.41.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/2\">",
"      ECC Committee, Subcommittees and Task Forces of the American Heart Association. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2005; 112:IV1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/3\">",
"      Kleinman ME, Chameides L, Schexnayder SM, et al. Part 14: pediatric advanced life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S876.",
"     </a>",
"    </li>",
"    <li>",
"     Walls RM. The decision to intubate. In: Manual of Emergency Airway Management, Walls RM, Murphy MF, Luten RC, Schneider RE.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/5\">",
"      Christ A, Arranto CA, Schindler C, et al. Incidence, risk factors, and outcome of aspiration pneumonitis in ICU overdose patients. Intensive Care Med 2006; 32:1423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/6\">",
"      Miller CD, Rebuck JA, Ahern JW, Rogers FB. Daily evaluation of macroaspiration in the critically ill post-trauma patient. Curr Surg 2005; 62:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/7\">",
"      Bleach NR. The gag reflex and aspiration: a retrospective analysis of 120 patients assessed by videofluoroscopy. Clin Otolaryngol Allied Sci 1993; 18:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/8\">",
"      Moulton C, Pennycook A, Makower R. Relation between Glasgow coma scale and the gag reflex. BMJ 1991; 303:1240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/9\">",
"      Davies AE, Kidd D, Stone SP, MacMahon J. Pharyngeal sensation and gag reflex in healthy subjects. Lancet 1995; 345:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/10\">",
"      Chan B, Gaudry P, Grattan-Smith TM, McNeil R. The use of Glasgow Coma Scale in poisoning. J Emerg Med 1993; 11:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/11\">",
"      Hummler HD, Engelmann A, Pohlandt F, et al. Decreased accuracy of pulse oximetry measurements during low perfusion caused by sepsis: Is the perfusion index of any value? Intensive Care Med 2006; 32:1428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/12\">",
"      Talke P, Stapelfeldt C. Effect of peripheral vasoconstriction on pulse oximetry. J Clin Monit Comput 2006; 20:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/13\">",
"      Bardi G, Pierotello R, Desideri M, et al. Nasal ventilation in COPD exacerbations: early and late results of a prospective, controlled study. Eur Respir J 2000; 15:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/14\">",
"      Bott J, Carroll MP, Conway JH, et al. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet 1993; 341:1555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/15\">",
"      Keenan SP, Kernerman PD, Cook DJ, et al. Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: a meta-analysis. Crit Care Med 1997; 25:1685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/16\">",
"      Confalonieri M, Aiolfi S, Gandola L, et al. Severe exacerbations of chronic obstructive pulmonary disease treated with BiPAP by nasal mask. Respiration 1994; 61:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/17\">",
"      Kramer N, Meyer TJ, Meharg J, et al. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 1995; 151:1799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22726/abstract/18\">",
"      Putinati S, Ballerin L, Piattella M, et al. Is it possible to predict the success of non-invasive positive pressure ventilation in acute respiratory failure due to COPD? Respir Med 2000; 94:997.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 268 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.98.179-4838B967EE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22726=[""].join("\n");
var outline_f22_12_22726=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DECIDING TO INTUBATE: FOUR QUESTION ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      IS THERE FAILURE OF AIRWAY MAINTENANCE OR PROTECTION?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      IS THERE FAILURE OF OXYGENATION?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      IS THERE FAILURE OF VENTILATION?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      IS THERE AN ANTICIPATED NEED FOR INTUBATION?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      APPROACH TO THE PATIENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/268\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/268|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?17/23/17790\" title=\"algorithm 1\">",
"      Decision to intubate",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=related_link\">",
"      Basic airway management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/18/44328?source=related_link\">",
"      Carbon dioxide monitoring (capnography)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=related_link\">",
"      Emergent endotracheal intubation in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/63/44024?source=related_link\">",
"      Ethical issues near the end of life",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1850?source=related_link\">",
"      Noninvasive positive pressure ventilation in acute respiratory failure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=related_link\">",
"      Oxygenation and mechanisms of hypoxemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=related_link\">",
"      Pulse oximetry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/55/1912?source=related_link\">",
"      Rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=related_link\">",
"      The difficult airway in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/51/18228?source=related_link\">",
"      The failed airway in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_12_22727="C3 glomerulonephritis IF";
var content_f22_12_22727=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F76040&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F76040&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 580px\">",
"   <div class=\"ttl\">",
"    Immunofluorescence microscopy in C3 glomerulonephritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 560px; height: 463px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immunofluorescence microscopy showing bright granular C3 staining on the mesangium and along capillary walls in a patient with C3 glomerulonephritis (40x).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Provided by Dr. Sanjeev Sethi, Department of Laboratory Medicine and Pathology, Mayo Clinic.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22727=[""].join("\n");
var outline_f22_12_22727=null;
var title_f22_12_22728="JXG leg";
var content_f22_12_22728=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F68132%7EDERM%2F81386%7EDERM%2F59377%7EDERM%2F69122&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F68132%7EDERM%2F81386%7EDERM%2F59377%7EDERM%2F69122&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Juvenile xanthogranuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Single yellow-orange nodule on the leg of an infant.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dr. Kate P&uuml;ttgen.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Juvenile xanthogranuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 226px; height: 159px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Single nodule of juvenile xanthogranuloma in the nasolabial fold of a child.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dr. Kate P&uuml;ttgen.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Juvenile xanthogranuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 352px; height: 219px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Single nodule of juvenile xanthogranuloma on the chin of a child.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dr. Kate P&uuml;ttgen.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Juvenile xanthogranuloma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical solitary lesion on the abdomen of an infant.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22728=[""].join("\n");
var outline_f22_12_22728=null;
var title_f22_12_22729="DiGeorge syndrome: Clinical features and diagnosis";
var content_f22_12_22729=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   DiGeorge syndrome: Clinical features and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/12/22729/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/12/22729/contributors\">",
"     Christine M Seroogy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/12/22729/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/12/22729/contributors\">",
"     E Richard Stiehm, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/12/22729/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/12/22729/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/12/22729/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 11, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H3601566\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;DiGeorge syndrome (DGS) is a constellation of signs and symptoms associated with defective development of the pharyngeal pouch system. Most cases are caused by a heterozygous chromosomal deletion at 22q11.2. Chromosome 22q11.2 deletion syndrome (22qDS) includes DGS and other similar syndromes, such as velocardiofacial syndrome. The classic triad of features of DGS on presentation is conotruncal cardiac anomalies, hypoplastic thymus, and hypocalcemia (resulting from parathyroid hypoplasia).",
"   </p>",
"   <p>",
"    Thymic hypoplasia in DGS results in a range of T cell deficits. Most patients with DGS have mild defects in T cell numbers and are not clinically immunodeficient. Approximately 1 percent, however, have a complete absence of thymic tissue and profound immunodeficiency. This form of DGS, called complete DGS, is a type of severe combined immune deficiency (SCID), and is life-threatening if not corrected with immune reconstitution.",
"   </p>",
"   <p>",
"    This topic reviews the clinical features and diagnosis of DGS. The epidemiology, pathogenesis, management, and prognosis of patients with DGS are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15608?source=see_link\">",
"     \"DiGeorge syndrome: Management and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25716807\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic triad of features of DGS on presentation is conotruncal cardiac anomalies, hypoplastic thymus, and hypocalcemia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/1\">",
"     1",
"    </a>",
"    ]. However, the phenotype is quite variable (",
"    <a class=\"graphic graphic_table graphicRef72911 \" href=\"UTD.htm?37/14/38123\">",
"     table 1",
"    </a>",
"    ) and there may be marked differences within a single family [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/2-6\">",
"     2-6",
"    </a>",
"    ]. Older children with DGS may be detected through clinics for congenital heart defects or craniofacial clinics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12143262\">",
"    <span class=\"h2\">",
"     Cardiac anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conotruncal cardiac defects occur in approximately 80 percent of DGS patients and when present, are typically the initial abnormalities noted [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/2,3,5\">",
"     2,3,5",
"    </a>",
"    ]. The term conotruncal refers to the distal portion of the fetal heart (trunco-aortic sac) at an early stage in development. The aortic and pulmonary roots subsequently develop from this area, and defects in these structures are referred to as conotruncal defects.",
"   </p>",
"   <p>",
"    The most common cardiac defects account for two-thirds of the cardiac anomalies seen in patients with DGS and include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/2,3,5,7,8\">",
"     2,3,5,7,8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Interrupted aortic arch",
"     </li>",
"     <li>",
"      Truncus arteriosus",
"     </li>",
"     <li>",
"      Tetralogy of Fallot",
"     </li>",
"     <li>",
"      Atrial or ventricular septal defects (ASD, VSD)",
"     </li>",
"     <li>",
"      Vascular rings",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The first three defects listed cause cyanotic heart disease in the newborn. Infants with an interrupted aortic arch may present with differential cyanosis, in which the upper half of the body is pink and the lower half is blue. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/56/20359?source=see_link\">",
"     \"Cardiac causes of cyanosis in the newborn\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/47/2809?source=see_link\">",
"     \"Truncus arteriosus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14218?source=see_link\">",
"     \"Congenital and pediatric coronary artery abnormalities\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most children with small ASDs and VSDs are asymptomatic, but infants with large defects may present with heart failure, failure to thrive,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    respiratory distress. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26201?source=see_link&amp;anchor=H16#H16\">",
"     \"Classification and clinical features of isolated atrial septal defects in children\", section on 'Presentation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8506?source=see_link&amp;anchor=H17#H17\">",
"     \"Pathophysiology and clinical features of isolated ventricular septal defects in infants and children\", section on 'Presentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical presentation of vascular rings varies depending upon the degree of tracheal and esophageal compression and can range from critical airway obstruction to stridor and feeding issues. Patients with incomplete vascular rings may be asymptomatic. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/5/27735?source=see_link\">",
"     \"Vascular rings\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14218?source=see_link\">",
"     \"Congenital and pediatric coronary artery abnormalities\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12143276\">",
"    <span class=\"h2\">",
"     Hypocalcemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocalcemia, resulting from underdevelopment of the parathyroid glands, is another potentially life-threatening manifestation of DGS. This develops in the newborn period in up to 60 percent of DGS patients, and may present with tetany, low serum calcium, elevated serum phosphorus, and very low parathyroid hormone levels. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36646?source=see_link\">",
"     \"Clinical manifestations of hypocalcemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Complications of hypocalcemia are unusual later in life secondary to presumed compensatory hyperplasia of existing parathyroid tissue. However, hypocalcemia can be precipitated by extreme stress in older patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/56/36744?source=see_link\">",
"     \"Parathyroid hormone secretion and action\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4519623\">",
"    <span class=\"h2\">",
"     Hypoplastic/aplastic thymus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The thymus is absent in patients with complete DGS. In patients with partial DGS, the thymus is present, although it is often reported as hypoplastic. However, the definition of thymic hypoplasia is inexact, since there are limited studies, particularly in children, to support the definition of a diminished size of the thymus in any condition or in normal individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link&amp;anchor=H5814537#H5814537\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\", section on 'Thymic hypoplasia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link&amp;anchor=H7#H7\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\", section on 'Immune function'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4670119\">",
"    <span class=\"h2\">",
"     Immunodeficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunodeficiency is common in patients with DGS and can range from recurrent sinopulmonary infections (partial DGS) to severe combined immunodeficiency (complete DGS). The severity of the immunodeficiency is related to the degree of thymic hypoplasia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link&amp;anchor=H5814537#H5814537\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\", section on 'Thymic hypoplasia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link&amp;anchor=H7#H7\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\", section on 'Immune function'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5815068\">",
"    <span class=\"h3\">",
"     SCID presentation (complete DGS)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete DGS is a form of severe combined immunodeficiency (SCID) and is found in less than 1 percent of patients with 22qDS. The thymus is absent and the T cell count is &lt;3 standard deviations below normal for age (typically &lt;50 naive CD3+ T",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     )",
"    </span>",
"    in these patients. In a large series of patients with complete DGS, 52 percent had an identifiable 22q11.2 deletion, while the remaining 48 percent did not have an identifiable chromosomal problem at the time of the study [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/12\">",
"     12",
"    </a>",
"    ]. Infants with complete DGS may be detected by newborn screening for T cell lymphopenia or by the development of recurrent severe infections, chronic diarrhea, and failure to thrive. This form of DGS is fatal unless recognized promptly after birth and treated with thymic or bone marrow transplant. (See",
"    <a class=\"local\" href=\"#H25718520\">",
"     'Evaluation in neonates'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15608?source=see_link&amp;anchor=H21#H21\">",
"     \"DiGeorge syndrome: Management and prognosis\", section on 'Immunologic management of complete DGS'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H665479\">",
"    <span class=\"h4\">",
"     \"Atypical\" complete DGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A subset of patients with profound T cell deficiency presents with or develops a leaky form of SCID, typically referred to as atypical complete DGS [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/13-16\">",
"     13-16",
"    </a>",
"    ]. These patients have oligoclonal populations of T cells in the periphery, with a T cell count that is higher than typical complete DGS patients, despite lacking a thymus, lymphadenopathy, and an eczematous dermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/17\">",
"     17",
"    </a>",
"    ]. These T cells may respond to mitogens in vitro and there is no evidence for maternal engraftment. Patients with atypical complete DGS can present with erythroderma, oligoclonal T cell expansion, lymphadenopathy, and elevated serum immunoglobulin E (IgE) levels may be best classified as Omenn syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/56/20362?source=see_link&amp;anchor=H13#H13\">",
"     \"T cell negative, B cell negative, NK cell positive severe combined immunodeficiency\", section on 'Omenn syndrome'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/56/20362?source=see_link&amp;anchor=H16#H16\">",
"     \"T cell negative, B cell negative, NK cell positive severe combined immunodeficiency\", section on 'Omenn syndrome phenotype'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6296705\">",
"    <span class=\"h3\">",
"     Partial DGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Overall, approximately 75 percent of patients with 22qDS are immunocompromised. Impaired T cell production occurs in most patients, although CD3+ T cell counts gradually improve in most patients. The improvement in CD3+ T cell counts reflects decreased age-related decline in T cell counts and increased accumulation of memory T cells secondary to lymphocytic homeostatic proliferation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/18\">",
"     18",
"    </a>",
"    ]. T cell function may also be abnormal, although the deficiency is not usually severe [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/19\">",
"     19",
"    </a>",
"    ]. Most patients with partial DGS do not suffer from opportunistic or life-threatening infections [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/20\">",
"     20",
"    </a>",
"    ]. However, many patients with partial DGS have a history of recurrent sinopulmonary infections [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/21\">",
"     21",
"    </a>",
"    ]. Humoral immune deficiencies are associated with partial DGS, including an increased prevalence of IgA deficiency and functional antibody defects (ie, polysaccharide antibody deficiency) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/22-25\">",
"     22-25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link&amp;anchor=H665764#H665764\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\", section on 'Partial DGS'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one study, up to one-third of patients had either recurrent sinusitis or otitis media, and a minority had bronchitis or pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/24\">",
"     24",
"    </a>",
"    ]. Recurrent and chronic sinusitis appears to be related to palatal abnormalities or gastroesophageal reflux in some patients, although polysaccharide antibody deficiency is also seen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17209?source=see_link\">",
"     \"Selective antibody deficiency with normal immunoglobulins\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24570?source=see_link\">",
"     \"Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7568451\">",
"    <span class=\"h2\">",
"     Other immune-related problems",
"    </span>",
"    &nbsp;&mdash;&nbsp;An increased incidence of autoimmune and atopic disease is seen in patients with DGS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7568458\">",
"    <span class=\"h3\">",
"     Autoimmune disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple studies have demonstrated an increased incidence of autoimmune phenomenon in patients with 22qDS [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/22,26-30\">",
"     22,26-30",
"    </a>",
"    ], suggesting an underlying defect in immune regulation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/18,31,32\">",
"     18,31,32",
"    </a>",
"    ]. The autoimmune diseases that are reported at an increased frequency in this population include autoimmune cytopenias, arthritis, and autoimmune thyroid disease. Five cases of juvenile polyarthritis with IgA deficiency in 22q11 syndrome were reported [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several case reports have documented that an autoimmune manifestation was the presenting symptom leading to the diagnosis of 22qDS [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link&amp;anchor=H665764#H665764\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\", section on 'Partial DGS'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7568588\">",
"    <span class=\"h3\">",
"     Allergic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atopic disease may also be a feature of 22qDS. One study demonstrated an increased incidence of asthma and eczema, but not allergic rhinitis, in 22qDS patients compared with the sibling control group [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5815285\">",
"    <span class=\"h2\">",
"     Craniofacial abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Possible facial abnormalities include low set and posteriorly rotated ears, ocular hypertelorism, and a bulbous nasal tip (",
"    <a class=\"graphic graphic_table graphicRef54237 \" href=\"UTD.htm?2/33/2587\">",
"     table 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef68022 \" href=\"UTD.htm?31/59/32692\">",
"     picture 1",
"    </a>",
"    ). These phenotypic findings are not specific for DGS. Similar features may be seen in patients with other chromosome 22q11.2 deletion syndromes, such as velocardiofacial syndrome, Opitz",
"    <span class=\"nowrap\">",
"     G/BBB",
"    </span>",
"    syndrome, and Cayler cardiofacial syndrome. Nasal dysmorphism, for example, was the one consistent finding in a series of 225 patients with 22q11.2 deletions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/37\">",
"     37",
"    </a>",
"    ]. The facial features in DGS often become less pronounced with age (",
"    <a class=\"graphic graphic_picture graphicRef68022 \" href=\"UTD.htm?31/59/32692\">",
"     picture 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/15/250?source=see_link&amp;anchor=H15#H15\">",
"     \"Syndromes with craniofacial abnormalities\", section on 'Velocardiofacial (Shprintzen) syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4519769\">",
"    <span class=\"h2\">",
"     Palatal and related problems",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other findings in infants with DGS include palatal and laryngotracheal abnormalities and related feeding difficulties [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/3,38,39\">",
"     3,38,39",
"    </a>",
"    ]. Palatal abnormalities include overt cleft palate and submucosal cleft palate. Velopharyngeal insufficiency in patients with DGS can be due to structural causes (eg, cleft palate)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    neuromuscular problems (eg, hypotonia) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/40\">",
"     40",
"    </a>",
"    ]. The most common findings of velopharyngeal insufficiency are hypernasal speech and nasal regurgitation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/1\">",
"     1",
"    </a>",
"    ]. Some of these signs and symptoms are subtle and may not come to medical attention. The causes, clinical features, and diagnosis of swallowing dysfunction are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/44/20169?source=see_link\">",
"     \"Etiology, prenatal diagnosis, obstetrical management, and recurrence of orofacial clefts\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/57/21399?source=see_link&amp;anchor=H11#H11\">",
"     \"Etiology of speech and language disorders in children\", section on 'Resonance disorders'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/46/38632?source=see_link\">",
"     \"Aspiration due to swallowing dysfunction in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5816053\">",
"    <span class=\"h2\">",
"     Developmental and behavioral problems",
"    </span>",
"    &nbsp;&mdash;&nbsp;Developmental delay occurs in the vast majority of patients with 22qDS, and speech delay is especially common (",
"    <a class=\"graphic graphic_table graphicRef72911 \" href=\"UTD.htm?37/14/38123\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/1,3,4,6,41-45\">",
"     1,3,4,6,41-45",
"    </a>",
"    ]. Intelligence ranges from normal to moderate intellectual disability. Patients typically score higher on verbal than performance measures. Problems in social-emotional functioning and inhibition and attention disorders may occur. Deficits in motor functioning have also been reported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7568764\">",
"    <span class=\"h2\">",
"     Other anomalies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients may also present with skeletal (eg, scoliosis) and structural genitourinary tract abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/1,3,38,46\">",
"     1,3,38,46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5816114\">",
"    <span class=\"h2\">",
"     Findings in adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adults with 22qDS have not been extensively studied [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/47,48\">",
"     47,48",
"    </a>",
"    ] and ascertainment bias is probably present in analyses of retrospective case series. Population-based studies are needed to better define the characteristics of adults with 22qDS.",
"   </p>",
"   <p>",
"    In the largest retrospective series of 126 adults, 60 percent were parents of affected children, and the others were patients in craniofacial, cardiology, genetics, and psychiatry clinics [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/48\">",
"     48",
"    </a>",
"    ]. Compared with a large series of children with 22qDS, adults had significantly lower rates of major cardiac anomalies (30 percent) and higher rates of palatal abnormalities (88 percent), mental disabilities (94 percent), and psychiatric conditions (36 percent). The most common findings were minor facial anomalies (99 percent) and hypernasal speech (",
"    <a class=\"graphic graphic_picture graphicRef52371 \" href=\"UTD.htm?9/26/9634\">",
"     picture 2",
"    </a>",
"    ). Psychiatric disorders included schizophrenia, schizoaffective disorder, and major depression. Hypocalcemia was reported in 15 percent and ranged in severity and age of onset (birth to 33 years). Thrombocytopenia or recurrent epistaxis was observed in 12 percent of patients, findings that are noted less frequently in infants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11654078\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of DGS is based upon reduced numbers of CD3+ T cells, combined with either characteristic clinical findings (eg, congenital cardiac anomalies, hypocalcemia, SCID) or a demonstrated deletion in chromosome 22q11.2. Proposed criteria define three diagnoses: definite, probable, and possible DGS (",
"    <a class=\"graphic graphic_table graphicRef55190 \" href=\"UTD.htm?42/2/43051\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/49\">",
"     49",
"    </a>",
"    ]. Approximately 90 percent of patients with DGS have heterozygous deletions in chromosome 22q11.2, although this deletion is less common in those with complete DGS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link&amp;anchor=H4#H4\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\", section on 'Genetic abnormalities'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Complete DGS is diagnosed by the presence of profound immune deficiency (low or absent T cell numbers and lack of proliferation to mitogens) and athymia. A 22q11.2 deletion is identified in only about 50 percent of patients with complete DGS [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/12,50\">",
"     12,50",
"    </a>",
"    ]. Complete DGS may also be identified on newborn screening for SCID that examines for the presence of T cell receptor excision circles (TRECs). TREC findings in DGS have not been systematically studied. However, excision circles were entirely absent in the few cases of complete DGS in which TREC results were reported [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link&amp;anchor=H6#H6\">",
"     \"Severe combined immunodeficiency (SCID): An overview\", section on 'Newborn screening'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25718520\">",
"    <span class=\"h2\">",
"     Evaluation in neonates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation for DGS should be considered for any neonate with a conotruncal heart lesion, hypocalcemia,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cleft palate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25718527\">",
"    <span class=\"h3\">",
"     Initial studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with suggestive signs and symptoms (",
"    <a class=\"graphic graphic_table graphicRef72911 \" href=\"UTD.htm?37/14/38123\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef54237 \" href=\"UTD.htm?2/33/2587\">",
"     table 2",
"    </a>",
"    ) should have the following performed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cardiac evaluation and echocardiogram (urgently)",
"     </li>",
"     <li>",
"      Serum calcium and phosphorus levels",
"     </li>",
"     <li>",
"      Complete blood count with differential to evaluate for lymphopenia",
"     </li>",
"     <li>",
"      Chest radiograph to evaluate for absence of a thymic shadow (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef67690 \" href=\"UTD.htm?28/56/29571\">",
"       image 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Renal ultrasound to assess for anomalies",
"     </li>",
"     <li>",
"      T and B cell subsets by fluorescence activated cell sorting (FACS)",
"     </li>",
"     <li>",
"      Immunoglobulin levels and if appropriate, antibody responses to vaccines",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The absence of a thymic shadow on chest imaging suggests some form of SCID, although the presence of a normal thymic shadow does not exclude DGS. Diminished thymic tissue is suggestive of an immune deficiency; however, this is an insensitive test since stress or infection can lead to thymic involution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25718534\">",
"    <span class=\"h3\">",
"     Advanced studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the thymus appears to be small or absent and lymphopenia is present, further evaluation of T and B cell function should be done quickly to assure that patients with complete DGS are identified. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link&amp;anchor=H7#H7\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\", section on 'Immune function'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This evaluation should include the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In vitro T cell proliferation in response to mitogens (such as the plant lectins phytohemagglutinin [PHA] or anti-CD3 antibody).",
"     </li>",
"     <li>",
"      Proliferative responses to neoantigens (such as vaccine antigens and Candida) are not useful in neonates who have not been exposed to these agents and have a maturing immune system, but can be used in older children and adults.",
"     </li>",
"     <li>",
"      Analysis of T cell receptor rearrangement excision circles (TRECs) is indicated for infants suspected of having complete DGS [",
"      <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/18,52\">",
"       18,52",
"      </a>",
"      ]. TREC analysis quantitates thymic output of T cells and is a more sensitive measure of thymic function than imaging of the thymus. This assay is commercially available and should be performed if T cell numbers are found to be very low. If TREC values are low alongside low T cells counts, determination of the frequency of na&iuml;ve T cells (CD45RA+) is informative to distinguish between complete DGS and a profound initial partial DGS presentation [",
"      <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/52\">",
"       52",
"      </a>",
"      ]. TREC analysis is not typically indicated in patients with partial DGS. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link&amp;anchor=H6#H6\">",
"       \"Severe combined immunodeficiency (SCID): An overview\", section on 'Newborn screening'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link&amp;anchor=H665093#H665093\">",
"       \"DiGeorge syndrome: Epidemiology and pathogenesis\", section on 'Complete DGS'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Flow cytometry can be used to determine T cell repertoire (TCR V&beta; chain diversity) and additional analysis for recent thymic emigrants should be considered (ie, CD31 expression).",
"     </li>",
"     <li>",
"      B cell function can be assessed by measuring IgM levels. IgG in neonates born after 34 weeks of gestation is of mixed",
"      <span class=\"nowrap\">",
"       maternal/infant",
"      </span>",
"      origin, and IgA levels can be undetectable in normal infants. In complete DGS, IgM is low or absent, as seen in other patients with SCID.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The laboratory evaluation of T and B cell function is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=see_link\">",
"     \"Laboratory evaluation of the immune system\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25718576\">",
"    <span class=\"h2\">",
"     Evaluation in older children and adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of DGS should be considered in older children and adults with consistent clinical findings, including characteristic facial features, developmental delay, palatal anomalies and hypernasal speech, and psychiatric problems (",
"    <a class=\"graphic graphic_table graphicRef72911 \" href=\"UTD.htm?37/14/38123\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef54237 \" href=\"UTD.htm?2/33/2587\">",
"     table 2",
"    </a>",
"    ). Clinical manifestations in different age groups are reviewed above. (See",
"    <a class=\"local\" href=\"#H25716807\">",
"     'Clinical presentation'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H5816114\">",
"     'Findings in adults'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Parameters for the initial assessment and ongoing monitoring of adults with the 22qDS have been proposed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/47\">",
"     47",
"    </a>",
"    ]. In addition to a comprehensive medical history and physical examination, the suggested initial evaluation includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Psychiatric and cognitive assessment",
"     </li>",
"     <li>",
"      Consultation with medical geneticist or genetics clinic experienced in 22qDS",
"     </li>",
"     <li>",
"      FISH for 22q11.2 deletion",
"     </li>",
"     <li>",
"      Complete blood count and differential",
"     </li>",
"     <li>",
"      Endocrine studies, including measurements of thyroid stimulating hormone, pH-corrected ionized calcium, parathyroid hormone, and serum creatinine",
"     </li>",
"     <li>",
"      Abdominal ultrasound to evaluate for renal abnormalities",
"     </li>",
"     <li>",
"      Echocardiogram",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1431580\">",
"    <span class=\"h2\">",
"     Genetic analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic studies are necessary to completely define the molecular basis for DGS, although they are not required to make a definitive diagnosis (",
"    <a class=\"graphic graphic_table graphicRef55190 \" href=\"UTD.htm?42/2/43051\">",
"     table 3",
"    </a>",
"    ). An appropriate initial step is to assay for a microdeletion at the critical DGS region of chromosome 22. Deletions in chromosome 22q11.2 can usually be detected by fluorescence in situ hybridization (FISH) using a probe specific for the commonly deleted region (",
"    <a class=\"graphic graphic_figure graphicRef65172 \" href=\"UTD.htm?42/50/43810\">",
"     figure 1",
"    </a>",
"    ). The two commercially available FISH probes, N25 (D22S75) (Oncor) and TUPLE1 (D22S553) (Vysis), detect virtually all patients with chromosome 22q11.2 microdeletions in the critical DGS region, and can be performed by many medical laboratories.",
"   </p>",
"   <p>",
"    If FISH analysis is negative for 22q11.2 deletions, then gene sequencing of",
"    <em>",
"     TBX1",
"    </em>",
"    can be performed through licensed laboratories to look for point mutations that would not be identified on FISH analysis. If",
"    <em>",
"     TBX1",
"    </em>",
"    sequencing is negative, a 10p13-14 FISH analysis for the DGSII locus (available through specialty centers) should be performed, since this is the next most common defect [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/53\">",
"     53",
"    </a>",
"    ]. If the FISH studies are negative for both of these DGS loci, then array comparative genomic hybridization (aCGH) or multiplex ligation probe amplification (MLPA), should be obtained to assess for other microdeletions or duplications [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/54\">",
"     54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=see_link\">",
"     \"DiGeorge syndrome: Epidemiology and pathogenesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28087?source=see_link\">",
"     \"Genomic disorders: An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=see_link\">",
"     \"Cytogenetic and molecular genetic diagnostic tools\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The inheritance of 22qDS is autosomal dominant, but the majority of cases are the result of de novo mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/55,56\">",
"     55,56",
"    </a>",
"    ]. The high population frequency of deletions in chromosome 22q11.2 appear to be linked to low copy repeats within or flanking this region [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/55\">",
"     55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28087?source=see_link&amp;anchor=H12440911#H12440911\">",
"     \"Genomic disorders: An overview\", section on 'Causes of CNVs'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25718590\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Given the complexity of the brachial-pharyngeal developmental sequence, it is not surprising that multiple genetic and teratogenic effects can result in common phenotypic outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25718597\">",
"    <span class=\"h2\">",
"     Other congenital syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several distinct clinical syndromes share phenotypic similarities with chromosome 22q11.2 deletion syndrome, including Zellweger, CHARGE, and Opitz",
"    <span class=\"nowrap\">",
"     G/BBB",
"    </span>",
"    syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/2,57\">",
"     2,57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25718604\">",
"    <span class=\"h3\">",
"     Zellweger syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Zellweger syndrome is a peroxisomal disorder that presents at birth with a typical craniofacial dysmorphism (",
"    <a class=\"graphic graphic_picture graphicRef72662 \" href=\"UTD.htm?19/62/20454\">",
"     picture 3",
"    </a>",
"    ). Unlike those with DGS, infants typically have hepatomegaly that is associated with cirrhosis and biliary dysgenesis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8570?source=see_link\">",
"     \"Peroxisomal disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25718611\">",
"    <span class=\"h3\">",
"     CHARGE syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with the CHARGE association (coloboma of the eye, heart anomalies, choanal atresia, retardation, genital and ear anomalies) share phenotypic features with patients with 22qDS, including cardiac defects, cleft palate, and hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/58-60\">",
"     58-60",
"    </a>",
"    ]. CHARGE is distinguished from DGS, however, by coloboma, choanal atresia, genital anomalies, and normal FISH for 22q11 deletions.",
"   </p>",
"   <p>",
"    One report described a patient with CHARGE and profound T cell lymphopenia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/61\">",
"     61",
"    </a>",
"    ]. A genetic mutation in the chromodomain helicase DNA-binding protein 7 (CHD7) gene was identified in this patient. A mutation in CHD7 is found in approximately 70 percent of patients fulfilling the criteria for CHARGE and this report provides the first link between CHD7 mutations and T cell lymphopenia. Since this report, five patients were described with CHD7 mutations and a complete DGS phenotype (T-B+NK+ SCID and Omenn syndrome) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/0/10?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): Specific defects\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A retrospective analysis of 25 patients with CHARGE association and confirmed CHD7 mutations described a spectrum of immunodeficiencies in the majority of this cohort [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/64\">",
"     64",
"    </a>",
"    ]. The incidence of lymphopenia was higher in the CHARGE association cohort compared with the 22q11.2 cohort at the author's institution, suggesting that immunologists should be part of the treatment team for CHARGE association patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25718618\">",
"    <span class=\"h3\">",
"     Opitz G/BBB syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Opitz",
"    <span class=\"nowrap\">",
"     G/BBB",
"    </span>",
"    syndrome is characterized by ocular hypertelorism, asymmetry of the skull, hypospadias, and laryngoesophageal defects [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/65\">",
"     65",
"    </a>",
"    ]. These features distinguish Opitz",
"    <span class=\"nowrap\">",
"     G/BBB",
"    </span>",
"    from DGS. The genetic basis for Opitz",
"    <span class=\"nowrap\">",
"     G/BBB",
"    </span>",
"    remains poorly characterized; however, several patients have been described with 22q11.2 microdeletions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/66\">",
"     66",
"    </a>",
"    ]. More sensitive genetic analysis on one patient with Opitz-like syndrome phenotype and 22q11.2 microdeletion demonstrated that this patient shared the same deletions as patients with DGS [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/67\">",
"     67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/52/23369?source=see_link&amp;anchor=H10#H10\">",
"     \"Causes and clinical manifestations of primary adrenal insufficiency in children\", section on 'Disorders of steroidogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1431882\">",
"    <span class=\"h3\">",
"     SCID",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other forms of SCID (ie, Omenn's syndrome), SCID with maternal T cell engraftment, or severe atopic dermatitis should be excluded in patients with suspected atypical complete DGS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): An overview\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/0/10?source=see_link\">",
"     \"Severe combined immunodeficiency (SCID): Specific defects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25718625\">",
"    <span class=\"h2\">",
"     Teratogen exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phenotypically similar patients have been described secondary to several in utero exposures, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/62/1000?source=see_link\">",
"     isotretinoin",
"    </a>",
"    or ethanol, or maternal conditions such as diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22729/abstract/57,68\">",
"     57,68",
"    </a>",
"    ]. In these cases, genetic abnormalities have not been identified and the phenotypic similarities are presumably a result of teratogen exposure at key developmental periods of neural crest cell migration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3601732\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The classic triad of features of DiGeorge syndrome on presentation is conotruncal cardiac anomalies, hypoplastic thymus, and hypocalcemia, although the phenotype is variable (",
"      <a class=\"graphic graphic_table graphicRef72911 \" href=\"UTD.htm?37/14/38123\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef54237 \" href=\"UTD.htm?2/33/2587\">",
"       table 2",
"      </a>",
"      ). Palatal abnormalities and developmental delay are common. (See",
"      <a class=\"local\" href=\"#H25716807\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Immunodeficiency is common in patients with DGS and can range from recurrent sinopulmonary infections (partial DGS) to severe combined immunodeficiency (complete DGS). The severity of the immunodeficiency is related to the degree of thymic hypoplasia. (See",
"      <a class=\"local\" href=\"#H4670119\">",
"       'Immunodeficiency'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other features of DGS that present outside of infancy and into adulthood include recurrent infections in patients with partial DGS, developmental delay, psychiatric abnormalities, and chronic inflammatory diseases (",
"      <a class=\"graphic graphic_table graphicRef72911 \" href=\"UTD.htm?37/14/38123\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H25716807\">",
"       'Clinical presentation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5816114\">",
"       'Findings in adults'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of and evaluation for DGS should occur for any neonate with a conotruncal heart lesion, hypocalcemia,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      cleft palate. This evaluation should proceed urgently, since clinical manifestations in the neonate can be life-threatening in the short term. (See",
"      <a class=\"local\" href=\"#H25718520\">",
"       'Evaluation in neonates'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis should be considered in older children and adults with consistent clinical findings (",
"      <a class=\"graphic graphic_table graphicRef72911 \" href=\"UTD.htm?37/14/38123\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef54237 \" href=\"UTD.htm?2/33/2587\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H25718576\">",
"       'Evaluation in older children and adults'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of DGS is based upon reduced numbers of CD3+ T cells, combined with either characteristic clinical findings or a demonstrated deletion in chromosome 22q11.2 (",
"      <a class=\"graphic graphic_table graphicRef55190 \" href=\"UTD.htm?42/2/43051\">",
"       table 3",
"      </a>",
"      ). Criteria have been proposed for definite, probable, and possible DGS. (See",
"      <a class=\"local\" href=\"#H11654078\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis includes exposure to teratogens and other congenital syndromes with similar clinical features. (See",
"      <a class=\"local\" href=\"#H25718590\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/1\">",
"      Bassett AS, McDonald-McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr 2011; 159:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/2\">",
"      McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) 2011; 90:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/3\">",
"      Ryan AK, Goodship JA, Wilson DI, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997; 34:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/4\">",
"      Vantrappen G, Devriendt K, Swillen A, et al. Presenting symptoms and clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience. Genet Couns 1999; 10:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/5\">",
"      McDonald-McGinn DM, Kirschner R, Goldmuntz E, et al. The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns 1999; 10:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/6\">",
"      Motzkin B, Marion R, Goldberg R, et al. Variable phenotypes in velocardiofacial syndrome with chromosomal deletion. J Pediatr 1993; 123:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/7\">",
"      McDonald-McGinn DM, LaRossa D, Goldmuntz E, et al. The 22q11.2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patients. Genet Test 1997; 1:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/8\">",
"      Goldmuntz E, Driscoll DA, Emanuel BS, et al. Evaluation of potential modifiers of the cardiac phenotype in the 22q11.2 deletion syndrome. Birth Defects Res A Clin Mol Teratol 2009; 85:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/9\">",
"      Hi&eacute;ronimus S, Bec-Roche M, Pedeutour F, et al. The spectrum of parathyroid gland dysfunction associated with the microdeletion 22q11. Eur J Endocrinol 2006; 155:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/10\">",
"      Harris JM, Hazenberg MD, Poulin JF, et al. Multiparameter evaluation of human thymic function: interpretations and caveats. Clin Immunol 2005; 115:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/11\">",
"      Kolte L, Dreves AM, Ersb&oslash;ll AK, et al. Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. J Infect Dis 2002; 185:1578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/12\">",
"      Markert ML, Devlin BH, Alexieff MJ, et al. Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood 2007; 109:4539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/13\">",
"      Markert ML, Alexieff MJ, Li J, et al. Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood 2004; 104:2574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/14\">",
"      Ozcan E, Notarangelo LD, Geha RS. Primary immune deficiencies with aberrant IgE production. J Allergy Clin Immunol 2008; 122:1054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/15\">",
"      Markert ML, Alexieff MJ, Li J, et al. Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. J Allergy Clin Immunol 2004; 113:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/16\">",
"      Vu QV, Wada T, Toma T, et al. Clinical and immunophenotypic features of atypical complete DiGeorge syndrome. Pediatr Int 2013; 55:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/17\">",
"      Selim MA, Markert ML, Burchette JL, et al. The cutaneous manifestations of atypical complete DiGeorge syndrome: a histopathologic and immunohistochemical study. J Cutan Pathol 2008; 35:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/18\">",
"      Piliero LM, Sanford AN, McDonald-McGinn DM, et al. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood 2004; 103:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/19\">",
"      Finocchi A, Di Cesare S, Romiti ML, et al. Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome). Pediatr Allergy Immunol 2006; 17:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/20\">",
"      Sullivan KE, Jawad AF, Randall P, et al. Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes. Clin Immunol Immunopathol 1998; 86:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/21\">",
"      Gennery AR. Immunological aspects of 22q11.2 deletion syndrome. Cell Mol Life Sci 2012; 69:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/22\">",
"      Gennery AR, Barge D, O'Sullivan JJ, et al. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child 2002; 86:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/23\">",
"      Smith CA, Driscoll DA, Emanuel BS, et al. Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Diagn Lab Immunol 1998; 5:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/24\">",
"      Jawad AF, McDonald-Mcginn DM, Zackai E, Sullivan KE. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J Pediatr 2001; 139:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/25\">",
"      Schubert MS, Moss RB. Selective polysaccharide antibody deficiency in familial DiGeorge syndrome. Ann Allergy 1992; 69:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/26\">",
"      Segni M, Zimmerman D. Autoimmune hyperthyroidism in two adolescents with DiGeorge/velocardiofacial syndrome (22q11 deletion). Eur J Pediatr 2002; 161:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/27\">",
"      Kratz CP, Niehues T, Lyding S, et al. Evans syndrome in a patient with chromosome 22q11.2 deletion syndrome: a case report. Pediatr Hematol Oncol 2003; 20:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/28\">",
"      Bruno B, Barbier C, Lambilliotte A, et al. Auto-immune pancytopenia in a child with DiGeorge syndrome. Eur J Pediatr 2002; 161:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/29\">",
"      Tison BE, Nicholas SK, Abramson SL, et al. Autoimmunity in a cohort of 130 pediatric patients with partial DiGeorge syndrome. J Allergy Clin Immunol 2011; 128:1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/30\">",
"      Choi JH, Shin YL, Kim GH, et al. Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome. Horm Res 2005; 63:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/31\">",
"      Chinen J, Rosenblatt HM, Smith EO, et al. Long-term assessment of T-cell populations in DiGeorge syndrome. J Allergy Clin Immunol 2003; 111:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/32\">",
"      Zemble R, Luning Prak E, McDonald K, et al. Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Immunol 2010; 136:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/33\">",
"      Davies K, Stiehm ER, Woo P, Murray KJ. Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome. J Rheumatol 2001; 28:2326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/34\">",
"      Davies JK, Telfer P, Cavenagh JD, et al. Autoimmune cytopenias in the 22q11.2 deletion syndrome. Clin Lab Haematol 2003; 25:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/35\">",
"      DePiero AD, Lourie EM, Berman BW, et al. Recurrent immune cytopenias in two patients with DiGeorge/velocardiofacial syndrome. J Pediatr 1997; 131:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/36\">",
"      Staple L, Andrews T, McDonald-McGinn D, et al. Allergies in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) and patients with chronic granulomatous disease. Pediatr Allergy Immunol 2005; 16:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/37\">",
"      Yagi H, Furutani Y, Hamada H, et al. Role of TBX1 in human del22q11.2 syndrome. Lancet 2003; 362:1366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/38\">",
"      Emanuel BS, McDonald-McGinn D, Saitta SC, Zackai EH. The 22q11.2 deletion syndrome. Adv Pediatr 2001; 48:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/39\">",
"      Leopold C, De Barros A, Cellier C, et al. Laryngeal abnormalities are frequent in the 22q11 deletion syndrome. Int J Pediatr Otorhinolaryngol 2012; 76:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/40\">",
"      Widdershoven JC, Spruijt NE, Spliet WG, et al. Histology of the pharyngeal constrictor muscle in 22q11.2 deletion syndrome and non-syndromic children with velopharyngeal insufficiency. PLoS One 2011; 6:e21672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/41\">",
"      Swillen A, Devriendt K, Legius E, et al. Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J Med Genet 1997; 34:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/42\">",
"      Gerdes M, Solot C, Wang PP, et al. Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet 1999; 85:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/43\">",
"      Moss EM, Batshaw ML, Solot CB, et al. Psychoeducational profile of the 22q11.2 microdeletion: A complex pattern. J Pediatr 1999; 134:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/44\">",
"      Wang PP, Woodin MF, Kreps-Falk R, Moss EM. Research on behavioral phenotypes: velocardiofacial syndrome (deletion 22q11.2). Dev Med Child Neurol 2000; 42:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/45\">",
"      Van Aken K, De Smedt B, Van Roie A, et al. Motor development in school-aged children with 22q11 deletion (velocardiofacial/DiGeorge syndrome). Dev Med Child Neurol 2007; 49:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/46\">",
"      Devriendt K, Swillen A, Fryns JP, et al. Renal and urological tract malformations caused by a 22q11 deletion. J Med Genet 1996; 33:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/47\">",
"      Bassett AS, Chow EW, Husted J, et al. Clinical features of 78 adults with 22q11 Deletion Syndrome. Am J Med Genet A 2005; 138:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/48\">",
"      Cohen E, Chow EW, Weksberg R, Bassett AS. Phenotype of adults with the 22q11 deletion syndrome: A review. Am J Med Genet 1999; 86:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/49\">",
"      Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999; 93:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/50\">",
"      Cleveland WW. Immunologic reconstitution in the DiGeorge syndrome by fetal thymic transplant. Birth Defects Orig Artic Ser 1975; 11:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/51\">",
"      Markert ML, Boeck A, Hale LP, et al. Transplantation of thymus tissue in complete DiGeorge syndrome. N Engl J Med 1999; 341:1180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/52\">",
"      Knutsen AP, Baker MW, Markert ML. Interpreting low T-cell receptor excision circles in newborns with DiGeorge anomaly: importance of assessing naive T-cell markers. J Allergy Clin Immunol 2011; 128:1375.",
"     </a>",
"    </li>",
"    <li>",
"     Testing for mutations in chromosome 10p is available at the Kleberg Cytogenetics Laboratory, Baylor College of Medicine, Houston, Texas. www.bcm.edu/geneticlabs (Accessed on April 23, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/54\">",
"      Jalali GR, Vorstman JA, Errami A, et al. Detailed analysis of 22q11.2 with a high density MLPA probe set. Hum Mutat 2008; 29:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/55\">",
"      Saitta SC, Harris SE, Gaeth AP, et al. Aberrant interchromosomal exchanges are the predominant cause of the 22q11.2 deletion. Hum Mol Genet 2004; 13:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/56\">",
"      Digilio MC, Angioni A, De Santis M, et al. Spectrum of clinical variability in familial deletion 22q11.2: from full manifestation to extremely mild clinical anomalies. Clin Genet 2003; 63:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/57\">",
"      Greenberg F. DiGeorge syndrome: an historical review of clinical and cytogenetic features. J Med Genet 1993; 30:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/58\">",
"      Devriendt K, Swillen A, Fryns JP. Deletion in chromosome region 22q11 in a child with CHARGE association. Clin Genet 1998; 53:408.",
"     </a>",
"    </li>",
"    <li>",
"     Online Medelian Inheritance in Man (OMIM) database. www.ncbi.nlm.nih.gov (Accessed on March 29, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/60\">",
"      Sanlaville D, Verloes A. CHARGE syndrome: an update. Eur J Hum Genet 2007; 15:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/61\">",
"      Sanka M, Tangsinmankong N, Loscalzo M, et al. Complete DiGeorge syndrome associated with CHD7 mutation. J Allergy Clin Immunol 2007; 120:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/62\">",
"      Inoue H, Takada H, Kusuda T, et al. Successful cord blood transplantation for a CHARGE syndrome with CHD7 mutation showing DiGeorge sequence including hypoparathyroidism. Eur J Pediatr 2010; 169:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/63\">",
"      Gennery AR, Slatter MA, Rice J, et al. Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome. Clin Exp Immunol 2008; 153:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/64\">",
"      Jyonouchi S, McDonald-McGinn DM, Bale S, et al. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features. Pediatrics 2009; 123:e871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/65\">",
"      Quaderi NA, Schweiger S, Gaudenz K, et al. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat Genet 1997; 17:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/66\">",
"      McDonald-McGinn DM, Driscoll DA, Bason L, et al. Autosomal dominant \"Opitz\" GBBB syndrome due to a 22q11.2 deletion. Am J Med Genet 1995; 59:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/67\">",
"      Erickson RP, D&iacute;az de St&aring;hl T, Bruder CE, Dumanski JP. A patient with 22q11.2 deletion and Opitz syndrome-like phenotype has the same deletion as velocardiofacial patients. Am J Med Genet A 2007; 143A:3302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22729/abstract/68\">",
"      Ammann AJ, Wara DW, Cowan MJ, et al. The DiGeorge syndrome and the fetal alcohol syndrome. Am J Dis Child 1982; 136:906.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 83396 Version 1.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-188.40.116.55-6D8648E745-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22729=[""].join("\n");
var outline_f22_12_22729=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3601732\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3601566\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25716807\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12143262\">",
"      Cardiac anomalies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12143276\">",
"      Hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4519623\">",
"      Hypoplastic/aplastic thymus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4670119\">",
"      Immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5815068\">",
"      - SCID presentation (complete DGS)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H665479\">",
"      \"Atypical\" complete DGS",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6296705\">",
"      - Partial DGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7568451\">",
"      Other immune-related problems",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7568458\">",
"      - Autoimmune disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7568588\">",
"      - Allergic disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5815285\">",
"      Craniofacial abnormalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4519769\">",
"      Palatal and related problems",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5816053\">",
"      Developmental and behavioral problems",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7568764\">",
"      Other anomalies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5816114\">",
"      Findings in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11654078\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25718520\">",
"      Evaluation in neonates",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25718527\">",
"      - Initial studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25718534\">",
"      - Advanced studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25718576\">",
"      Evaluation in older children and adults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1431580\">",
"      Genetic analysis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25718590\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25718597\">",
"      Other congenital syndromes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25718604\">",
"      - Zellweger syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25718611\">",
"      - CHARGE syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25718618\">",
"      - Opitz G/BBB syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1431882\">",
"      - SCID",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25718625\">",
"      Teratogen exposure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3601732\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ALLRG/83396\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/83396|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/56/29571\" title=\"diagnostic image 1\">",
"      Chest x-rays with and without thymic shadows",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/83396|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/50/43810\" title=\"figure 1\">",
"      DiGeorge chrom 22",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/83396|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/59/32692\" title=\"picture 1\">",
"      DiGeorge pt infant adolesc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/26/9634\" title=\"picture 2\">",
"      DiGeorge adult facies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/62/20454\" title=\"picture 3\">",
"      Zellweger syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ALLRG/83396|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/14/38123\" title=\"table 1\">",
"      Clin finding 22q11 deletion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/33/2587\" title=\"table 2\">",
"      DiGeorge features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/2/43051\" title=\"table 3\">",
"      Diagnosis of DiGeorge syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/46/38632?source=related_link\">",
"      Aspiration due to swallowing dysfunction in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/56/20359?source=related_link\">",
"      Cardiac causes of cyanosis in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/52/23369?source=related_link\">",
"      Causes and clinical manifestations of primary adrenal insufficiency in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26201?source=related_link\">",
"      Classification and clinical features of isolated atrial septal defects in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36646?source=related_link\">",
"      Clinical manifestations of hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14218?source=related_link\">",
"      Congenital and pediatric coronary artery abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28536?source=related_link\">",
"      Cytogenetic and molecular genetic diagnostic tools",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32343?source=related_link\">",
"      DiGeorge syndrome: Epidemiology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/15/15608?source=related_link\">",
"      DiGeorge syndrome: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/57/21399?source=related_link\">",
"      Etiology of speech and language disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/44/20169?source=related_link\">",
"      Etiology, prenatal diagnosis, obstetrical management, and recurrence of orofacial clefts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28087?source=related_link\">",
"      Genomic disorders: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/58/43945?source=related_link\">",
"      Laboratory evaluation of the immune system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/56/36744?source=related_link\">",
"      Parathyroid hormone secretion and action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8506?source=related_link\">",
"      Pathophysiology and clinical features of isolated ventricular septal defects in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8570?source=related_link\">",
"      Peroxisomal disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24570?source=related_link\">",
"      Selective IgA deficiency: Clinical manifestations, pathophysiology, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/51/17209?source=related_link\">",
"      Selective antibody deficiency with normal immunoglobulins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/30/42471?source=related_link\">",
"      Severe combined immunodeficiency (SCID): An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/0/10?source=related_link\">",
"      Severe combined immunodeficiency (SCID): Specific defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/15/250?source=related_link\">",
"      Syndromes with craniofacial abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/56/20362?source=related_link\">",
"      T cell negative, B cell negative, NK cell positive severe combined immunodeficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/47/2809?source=related_link\">",
"      Truncus arteriosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/5/27735?source=related_link\">",
"      Vascular rings",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_12_22730="Surgical management of gallbladder cancer";
var content_f22_12_22730=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surgical management of gallbladder cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/12/22730/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/12/22730/contributors\">",
"     Richard Swanson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/12/22730/contributors\">",
"     Bhoomi Mehrotra, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/12/22730/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/12/22730/contributors\">",
"     Stanley W Ashley, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/12/22730/contributors\">",
"     Kenneth K Tanabe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/12/22730/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/12/22730/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/12/22730/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/12/22730/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H111050694\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gallbladder cancer is an uncommon but highly fatal malignancy with fewer than 5000 new cases diagnosed each year in the United States. Most gallbladder cancers are found incidentally in patients undergoing exploration for cholelithiasis. Tumor is found in .025 to 3 percent of patients undergoing cholecystectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. The overall poor prognosis associated with GBC is related to the often advanced stage at diagnosis. For patients with early stage (T1) disease, long-term survival rates range from 85 to 100 percent. Unfortunately, fewer than 10 percent of symptomatic patients and only about 20 percent of patients with incidentally diagnosed gallbladder cancer have early-stage disease.",
"   </p>",
"   <p>",
"    The surgical management of gallbladder cancer is reviewed here. The clinical evaluation and diagnosis of gallbladder cancer and nonsurgical management of gallbladder cancer are discussed elsewhere. The management of cholangiocarcinoma is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/24/43399?source=see_link\">",
"     \"Adjuvant treatment for localized, potentially resectable gallbladder cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/11/33977?source=see_link\">",
"     \"Treatment of advanced, unresectable gallbladder cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/33/25114?source=see_link\">",
"     \"Treatment of localized cholangiocarcinoma: Surgical management and adjuvant therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H738297\">",
"    <span class=\"h1\">",
"     GALLBLADDER ANATOMY AND PHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gallbladder is a small, pear-shaped organ that is located inferior to the margin of the right lobe of the liver (",
"    <a class=\"graphic graphic_figure graphicRef71755 \" href=\"UTD.htm?14/48/15106\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The gallbladder is divided into distinct segments: the fundus, body, infundibulum and the neck [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The fundus is the expanded end of the gallbladder that projects away from the margin of the liver. It is anatomically associated with the anterior abdominal wall and hepatic flexure of the colon.",
"     </li>",
"     <li>",
"      The body of the gallbladder is attached to the liver by loose connective tissue superiorly. Inferiorly, the free margin abuts the duodenum and transverse colon. Superiorly it is anatomically associated with segments IV and V of the liver (",
"      <a class=\"graphic graphic_figure graphicRef81897 \" href=\"UTD.htm?13/35/13878\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The neck of the gallbladder extends from the body to the cystic duct.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The cystic duct joins the common bile duct along its course from the liver to the duodenum. The level of the juncture and course of the cystic duct can vary (",
"    <a class=\"graphic graphic_figure graphicRef69483 \" href=\"UTD.htm?6/10/6307\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The gallbladder is supplied by the cystic artery, which is a branch of the right hepatic artery. The cystic artery courses along the cystic duct and divides at the neck of the gallbladder into superficial and deep branches, which supply in the",
"    <span class=\"nowrap\">",
"     anterior/inferior",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     posterior/superior",
"    </span>",
"    aspects of the gallbladder, respectively. The cystic artery or an accessory cystic artery can arise from the right hepatic, left hepatic, or common hepatic artery (",
"    <a class=\"graphic graphic_figure graphicRef56280 \" href=\"UTD.htm?18/3/18481\">",
"     figure 4",
"    </a>",
"    ). The venous drainage of the gallbladder generally parallels the course of the arteries draining into the cystic vein, which drains into the gallbladder fossa directly into the right hepatic vein (ie, it does not accompany the cystic artery) (",
"    <a class=\"graphic graphic_figure graphicRef81897 \" href=\"UTD.htm?13/35/13878\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The sympathetic nerves that supply the gallbladder are derived from the ninth thoracic segment and from the celiac plexus. The phrenic nerve on the right contributes a few somatic fibers.",
"   </p>",
"   <p>",
"    The primary function of the gallbladder is the storage of bile, a fluid produced by the liver that aids with the digestion of fat. Bile is released into the duodenum in response to cholecystokinin (CCK), the major hormone responsible for gallbladder contraction and pancreatic enzyme secretion. CCK is produced in discrete endocrine cells that line the mucosa of the small intestine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35638?source=see_link\">",
"     \"Physiology of cholecystokinin\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H740004\">",
"    <span class=\"h2\">",
"     Lymphatic drainage",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lymphatic drainage of the gallbladder is via several pathways and does not always follow a predictable drainage pattern [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]. In some cases, lymph nodes associated with gallbladder cancer can first be seen posterior to the pancreas or portal vein [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link&amp;anchor=H28#H28\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\", section on 'TNM staging system'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The cholecysto-retropancreatic pathway is the principal pathway and drains along the cystic duct (cystic nodes), common bile duct (pericholedochal nodes), portal vein (retroportal node), and posterior pancreas (superior retropancreaticoduodenal node) to the paraaortic region (paraaortic nodes). In one study, this route was stained in 95 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The cholecysto-celiac pathway, the next most common pathway, drains along the cystic duct (cystic nodes) and medially along the hepatoduodenal ligament posterior to the head of the pancreas to the portal vein and celiac axis. Among lymph nodes along this route, one study found that the posterior common hepatic node was most frequently stained (45 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The cholecysto-mesenteric pathway drains to the left in front of the portal vein connecting with the nodes at the root of the mesentery (superior mesenteric nodes).",
"     </li>",
"     <li>",
"      A hilar route that ascends directly toward the hepatic hilum has been described in an animal model [",
"      <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The cystic duct, common bile duct, hepatic artery, and portal vein lymph nodes are considered N1 according to the American Joint Committee on Cancer (AJCC) 7 staging manual [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/10\">",
"     10",
"    </a>",
"    ]. The paraaortic, pericaval, superior mesenteric artery, and celiac lymph nodes are N2 nodes that are designated Stage IVb due to the poor prognosis associated with their involvement. Thus, lymphadenectomy is generally not performed beyond the hepatoduodenal ligament. (See",
"    <a class=\"local\" href=\"#H1159119845\">",
"     'Staging'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H741641\">",
"    <span class=\"h1\">",
"     CLINICAL SCENARIOS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gallbladder cancer may be diagnosed preoperatively, intraoperatively at the time of surgical exploration for abdominal symptoms attributable to another disease process, or postoperatively upon examination of the gallbladder specimen typically removed for cholecystectomy due to cholelithiasis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In some cases, gallbladder cancer is diagnosed or suspected preoperatively. Patients with right upper abdominal pain, and particularly those with jaundice or signs of duodenal obstruction, more typically have locally advanced disease that may be identified preoperatively. Risk factors for gallbladder cancer including large gallstones, calcified (porcelain) gallbladder, gallbladder polyps, and congenital biliary cysts among others may point toward a diagnosis of gallbladder cancer preoperatively. The risk factors for gallbladder cancer and diagnostic evaluation are discussed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link&amp;anchor=H3#H3\">",
"       \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\", section on 'Risk factors'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with early, invasive, potentially curable gallbladder cancer are often asymptomatic, or may have nonspecific symptoms that mimic, or are due to cholelithiasis or cholecystitis. Because the symptoms are nonspecific, gallbladder cancer is not typically suspected preoperatively. Gallbladder cancer may be identified or strongly suspected at surgical exploration (open or laparoscopic) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/1\">",
"       1",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H1159124143\">",
"       'Managing an incidental gallbladder cancer'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      A common scenario leading to a diagnosis of gallbladder cancer is the return of a final pathology report indicating gallbladder cancer in a resected gallbladder specimen [",
"      <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/2,11,12\">",
"       2,11,12",
"      </a>",
"      ]. Incidental gallbladder cancer is found in 0.25 and 3.0 percent in patients undergoing laparoscopic cholecystectomy [",
"      <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/1-3,11,13-16\">",
"       1-3,11,13-16",
"      </a>",
"      ]. The extent of tumor invasion (T-stage) is indicated on the pathology report and may indicate the need for re-resection. In one retrospective study of six major hepatobiliary centers, the majority (92 percent) of patients with incidental gallbladder cancer had T2 (67 percent) and T3 (25 percent) disease [",
"      <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/17\">",
"       17",
"      </a>",
"      ]. Incidentally discovered gallbladder cancer has a high rate of extra-cholecystic disease. In the cohort of patients with incidentally discovered gallbladder cancer who underwent re-resection, 28 patients had evidence of distant hepatic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      peritoneal metastases. (See",
"      <a class=\"local\" href=\"#H1159119845\">",
"       'Staging'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H1159124143\">",
"       'Managing an incidental gallbladder cancer'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1159119845\">",
"    <span class=\"h1\">",
"     STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Joint Committee on Cancer (AJCC) TNM staging classification of gallbladder cancer is the preferred classification in the United States and is shown in the table (",
"    <a class=\"graphic graphic_table graphicRef70554 \" href=\"UTD.htm?6/41/6813\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/10\">",
"     10",
"    </a>",
"    ]. Other classification schemes and the distribution of disease by stage are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link&amp;anchor=H26#H26\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\", section on 'Staging'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of distant metastases increases as T stage increases. In one review, peritoneal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    liver metastases were present in 16, 42, and 79 percent of patients with T2, T3, and T4 disease, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/18\">",
"     18",
"    </a>",
"    ]. Lymphatic metastases are found in 35 to 80 percent of patients with &ge;T2 disease at diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/19-23\">",
"     19-23",
"    </a>",
"    ]. Due to advanced disease, only 15 to 47 percent of patients are candidates for resection at time of diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/24\">",
"     24",
"    </a>",
"    ]. Thus, staging prior to considering resection is important and can be accomplished using a combination of preoperative imaging and diagnostic laparoscopy, which are discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1159123350\">",
"    <span class=\"h2\">",
"     Preoperative imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;When surgery is being considered in a patient with documented or suspected gallbladder cancer, preoperative imaging is important to identify patients with absolute contraindications to resection. Although preoperative imaging detects extracholecystic disease, it is insensitive for peritoneal disease, which is present in 30 to 75 percent of patients and requires diagnostic staging laparoscopy for detection. (See",
"    <a class=\"local\" href=\"#H1159123466\">",
"     'Diagnostic staging laparoscopy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The incidence of patients undergoing nontherapeutic exploratory laparotomy for locally unresectable malignancy has significantly diminished with high-quality, high-resolution preoperative imaging. However, there are no definitive guidelines for imaging prior to surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/2,25\">",
"     2,25",
"    </a>",
"    ]. Cross-sectional imaging can be obtained using multidetector contrast enhanced computed tomography, contrast-enhanced magnetic resonance (MR) imaging or MR cholangiopancreatography. In selected cases where metastatic disease is suspected, fluorodeoxyglucose-positron emission tomography (FDG-PET) can be used. Most (86 percent) of gallbladder cancer is FDG-avid [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. In a retrospective study of 93 patients with biliary tract cancer who underwent preoperative FDG-PET scans, the results changed the stage and treatment of 24 percent of the patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/26\">",
"     26",
"    </a>",
"    ]. The sensitivity of these modalities in the diagnosis and staging of gallbladder cancer is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link&amp;anchor=H18#H18\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\", section on 'Diagnostic evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1159123466\">",
"    <span class=\"h2\">",
"     Diagnostic staging laparoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic staging laparoscopy is necessary prior to resection to identify absolute contraindications that may not be apparent on preoperative imaging studies. (See",
"    <a class=\"local\" href=\"#H99392790\">",
"     'Contraindications to resection'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Diagnostic staging laparoscopy frequently identifies metastatic disease or other findings that contraindicate tumor resection [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/2,28-30\">",
"     2,28-30",
"    </a>",
"    ]. As an example, in one prospective study of diagnostic staging laparoscopy in patients with gallbladder cancer, peritoneal disease was detected in 21 out of 44 patients, even with negative preoperative high-resolution multiple modality imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/28\">",
"     28",
"    </a>",
"    ]. The general principles of diagnostic staging laparoscopy for digestive malignancies are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/39/15992?source=see_link\">",
"     \"Diagnostic staging laparoscopy: General principles for staging primary digestive malignancies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because gallbladder cancer frequently extends directly to adjacent structures such as the liver, stomach, duodenum, pancreas, colon, omentum, or the abdominal wall, diagnostic staging laparoscopy may provide valuable information on extent of disease. Laparoscopic ultrasound should be employed as adjunctive imaging to look for satellite lesions in the liver, define the location of the gallbladder tumor, the relationship of the tumor to surrounding blood vessels, and the likelihood of attaining an adequate margin of liver [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/39/15992?source=see_link&amp;anchor=H22894891#H22894891\">",
"     \"Diagnostic staging laparoscopy: General principles for staging primary digestive malignancies\", section on 'Laparoscopic ultrasound'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H99392790\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS TO RESECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Absolute contraindications to surgery for gallbladder cancer include liver metastasis, peritoneal metastases, involvement of N2 nodes (celiac, peripancreatic, periduodenal, or superior mesenteric nodes) malignant ascites, extensive involvement of the hepatoduodenal ligament, and encasement or occlusion of major vessels. If any of these are confirmed preoperatively on imaging studies, the disease is incurable and surgery should only be considered to palliate specific problems. Direct involvement of colon, duodenum, or liver does not represent an absolute contraindication. If no contraindications are identified, a diagnostic laparoscopy is performed prior to resection to confirm the absence of peritoneal or metastatic disease. (See",
"    <a class=\"local\" href=\"#H1159119845\">",
"     'Staging'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Patients found to have contraindications to resection based upon preoperative imaging, laparoscopic staging, or intraoperative exploration because of major encasement of vascular structures should be referred for chemotherapy alone or chemoradiotherapy. There is no role for a palliative noncurative radical surgery, for the purpose of debulking, and any subsequent attempts at resection should be undertaken only if it is possible to achieve a complete resection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/11/33977?source=see_link\">",
"     \"Treatment of advanced, unresectable gallbladder cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although the value of a debulking simple cholecystectomy has not been definitely proven in this situation, this approach is recommended by some to prevent future episodes of cholecystitis in patients with locally unresectable disease. The optimal way to manage these patients has not been established, and treatment must be individualized based on extent and resectability of the disease and experience of the management team. (See",
"    <a class=\"local\" href=\"#H1228877466\">",
"     'Palliative procedures'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H99392019\">",
"    <span class=\"h1\">",
"     SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery is the only potentially curative therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/32\">",
"     32",
"    </a>",
"    ]. Gallbladder cancers that are categorized as stage 0, I or II (ie, T stage Tis, T1 or T2) are potentially resectable with curative intent (",
"    <a class=\"graphic graphic_table graphicRef70554 \" href=\"UTD.htm?6/41/6813\">",
"     table 1",
"    </a>",
"    ). Stage T3 tumors are generally locally unresectable due to vascular invasion or involvement of multiple adjacent organs; however, resection may be possible. Stage IVa (T4, N0-1, M0) is occasionally resectable. Stage IVb, M1, or N2 disease represents unresectable disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link\">",
"     \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgical treatment of gallbladder cancer involves removal of the gallbladder (cholecystectomy) typically with a rim of liver tissue (extended cholecystectomy), except in T1a disease, and may include bile duct resection, lymph node resection, more extensive liver resection, or resection of involved adjacent organs [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H99392991\">",
"    <span class=\"h2\">",
"     General approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once intraabdominal metastatic disease has been ruled out with diagnostic laparoscopy, the surgeon can proceed with the resection. (See",
"    <a class=\"local\" href=\"#H1159123466\">",
"     'Diagnostic staging laparoscopy'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    An open rather than laparoscopic procedure is generally recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/34-38\">",
"     34-38",
"    </a>",
"    ], although some data suggest the feasibility of a planned laparoscopic approach for an early-stage (T1a) gallbladder cancer, the only group for whom the risk of nodal metastases is sufficiently low that more radical resection can be avoided (",
"    <a class=\"graphic graphic_table graphicRef70554 \" href=\"UTD.htm?6/41/6813\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/39\">",
"     39",
"    </a>",
"    ]. However, preoperative staging is not entirely reliable at identifying patients with T1a disease, and improperly staged tumors are at risk for inadequate resection and subsequent recurrence. When a laparoscopic approach has been performed, resection of the port sites is advocated by some groups, but is generally not necessary. (See",
"    <a class=\"local\" href=\"#H111058036\">",
"     'T1 gallbladder cancer'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H90813616\">",
"     'Laparoscopic port site resection'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Open gallbladder surgery is usually performed through a right subcostal incision. Additional exposure can be obtained with extension to the upper midline or to the left subcostal region as a chevron incision. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30265?source=see_link&amp;anchor=H3294660#H3294660\">",
"     \"Principles of abdominal wall incisions\", section on 'Subcostal'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Once the abdomen is entered and retractors are placed, simple cholecystectomy (T1a) or extended cholecystectomy (&gt;T1a) is performed depending on the T stage of the disease. Resection of adherent involved, adjacent organs may be necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H1228870938\">",
"     'Cholecystectomy versus extended cholecystectomy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Following cholecystectomy or extended cholecystectomy, the specimen is sent for frozen section to evaluate the margins of the specimen. A more extensive liver resection may be needed to achieve negative margins (eg, tumors of the gallbladder neck). A frozen section analysis of the cystic duct stump should also be performed. Cystic duct margin status predicts residual disease in the common bile duct [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/17\">",
"     17",
"    </a>",
"    ]. If the cystic duct stump is negative for tumor, a regional lymph node dissection is performed (except T1a tumors). On the other hand, if it is positive, then regional lymphadenectomy plus extrahepatic bile duct resection is undertaken. (See",
"    <a class=\"local\" href=\"#H604313386\">",
"     'Bile duct resection'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H604312644\">",
"     'Lymph node dissection'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    For patients in whom the diagnosis of &gt;T1a gallbladder cancer is made incidentally, the surgical management is similar to primary resection of gallbladder cancer (preoperative or intraoperative diagnosis). However, the gallbladder will have already been removed. The status of the cystic duct stump on the pathology report determines the need for lymph node dissection and bile duct resection. (See",
"    <a class=\"local\" href=\"#H1159124143\">",
"     'Managing an incidental gallbladder cancer'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1228870938\">",
"    <span class=\"h2\">",
"     Cholecystectomy versus extended cholecystectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whether to perform cholecystectomy alone, or extended cholecystectomy, which resects a rim of liver in the region of the gallbladder bed, is determined largely by the tumor (T) stage (",
"    <a class=\"graphic graphic_table graphicRef70554 \" href=\"UTD.htm?6/41/6813\">",
"     table 1",
"    </a>",
"    ), once it becomes known. The T-stage may be estimated preoperatively based upon imaging, or determined by intraoperative frozen section analysis or final pathology specimen following cholecystectomy. It is important to remember that preoperative staging (imaging, laparoscopic) is not entirely reliable at identifying patients as having disease limited to the lamina propria [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/39\">",
"     39",
"    </a>",
"    ]. Deeper invasion confirmed on pathology studies may indicate the need for re-resection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H111058036\">",
"    <span class=\"h3\">",
"     T1 gallbladder cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Simple cholecystectomy alone is felt to be adequate for patients with tumors that are limited to the lamina propria (T1a). Cure rates following simple cholecystectomy range from 73 to 100 percent in case series [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/13,40-44\">",
"     13,40-44",
"    </a>",
"    ]. Patients found to have incidental T1a tumors with negative margins are generally felt to be curable with the cholecystectomy that has already been performed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/31,43,45-49\">",
"     31,43,45-49",
"    </a>",
"    ]. Re-resection for T1a tumors does not appear to provide an overall survival benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/50-53\">",
"     50-53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <br/>",
"    Patients with stage T1b disease may benefit from a more radical approach, given that T1b tumors are associated with a higher incidence of lymph node metastases compared with T1a tumors (15 versus 2.5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/40,41,43,54-56\">",
"     40,41,43,54-56",
"    </a>",
"    ]. Some investigators have shown a median survival advantage of over three years for extended versus cholecystectomy alone for T1b cancers (9.85 versus 6.42 years, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/57\">",
"     57",
"    </a>",
"    ]. Extended cholecystectomy (cholecystectomy including a rim of liver tissue) should be performed for medically-fit patients who have tumors that invade the muscular layer (T1b) (",
"    <a class=\"graphic graphic_table graphicRef70554 \" href=\"UTD.htm?6/41/6813\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H966253\">",
"     'Extended cholecystectomy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The optimal approach to T1b disease is more controversial. If there is no contraindication to surgery, extended resection is reasonable for T1b gallbladder cancer. At least two retrospective studies comparing cholecystectomy alone versus extended cholecystectomy for T1b tumors found no significant difference in overall survival (with up to 87 percent 10",
"    <strong>",
"     -",
"    </strong>",
"    year survival). Others have reported improved survival with re-resection [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/58\">",
"     58",
"    </a>",
"    ]. Furthermore, a number of studies describe high rates of residual disease upon re-resection, with lymph node metastases in 12 to 20 percent and 0 to 13 percent with liver involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/17,22\">",
"     17,22",
"    </a>",
"    ]. Two reports describe up to a 50 to 60 percent locoregional recurrence rate, with associated death, after cholecystectomy alone for T1b disease [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/59\">",
"     59",
"    </a>",
"    ]. The authors of both reports concluded that gallbladder cancer is a locally aggressive disease and even early-stage disease warrants extended resection. Finally, as noted above, decision analysis showed a median survival advantage of over three years for extended versus simple cholecystectomy (9.85 versus 6.42 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H111058043\">",
"    <span class=\"h3\">",
"     T2 gallbladder cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extended cholecystectomy should also be performed in patients with T2 tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/52,60\">",
"     52,60",
"    </a>",
"    ]. The need to perform a more aggressive resection is supported by the high rate of residual disease discovered on re-resection for T2 disease discovered incidentally. In a retrospective study of six major hepatobiliary centers, upon re-resection of T2 tumors found incidentally, residual disease was found in 57 percent of the patients at any site; lymph nodes were involved in 31 percent, and the liver was involved in 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/17\">",
"     17",
"    </a>",
"    ]. Lymph node metastases have been seen in up to 62 percent of patients with T2 disease [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/61\">",
"     61",
"    </a>",
"    ]. Given the high rate of residual disease seen after re-resection of T2 disease, it is not surprising that high rates of positive margins (11 out of 25 with positive margins in one study) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/44\">",
"     44",
"    </a>",
"    ], and high rates of local recurrence (40 percent) are found in patients with T2 treated with cholecystectomy alone [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/62\">",
"     62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients with an incidentally detected T2 tumor on histologic review of the cholecystectomy specimen, reexploration and extended cholecystectomy are also indicated. Reexploration identifies residual tumor in 40 to 76 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/1,19,21,40,41\">",
"     1,19,21,40,41",
"    </a>",
"    ], a high likelihood of liver involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/63,64\">",
"     63,64",
"    </a>",
"    ], and nodal metastases with T2 disease. Re-resection significantly increases the likelihood of long-term disease-free survival in patients with T2 disease. In many series, five-year survival rates increased from 24 to 40 percent to 80 to 100 percent with aggressive surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/18,19,21,40,41,44,54,55,65-69\">",
"     18,19,21,40,41,44,54,55,65-69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As an example, in an analysis of 3209 patients with early-stage gallbladder cancer (12 percent Tis, 30 percent T1, 58 percent T2) derived from the Surveillance, Epidemiology, and End Results (SEER) database, extended resection with lymph node excision was associated with increased survival compared with cholecystectomy alone [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/70\">",
"     70",
"    </a>",
"    ]. However, a significant survival advantage for extended resection was seen only in patients with",
"    <sup>",
"    </sup>",
"    T2 lesions (hazard ratio [HR] 0.49, 95% CI 0.35-0.68). Lymph node excision also significantly improved",
"    <sup>",
"    </sup>",
"    survival in patients with T2 lesions and was related to the number of lymph nodes removed (HR 0.42, 95% CI 0.33-0.53 for one to four",
"    <sup>",
"    </sup>",
"    lymph nodes excised; HR 0.26, CI 0.16-0.42 for five lymph nodes excised). Based upon these survival differences, one report suggests that for gallbladder cancer to be considered node negative, at least six lymph nodes should have been removed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1228870927\">",
"    <span class=\"h3\">",
"     Resectable T3/4 or node positive gallbladder cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the past, surgeons were reluctant to operate on patients with locally advanced",
"    <span class=\"nowrap\">",
"     (T3/4)",
"    </span>",
"    disease because of an overall poor prognosis. Although some series document poor survival even with extended resection [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/72\">",
"     72",
"    </a>",
"    ], support for radical surgery in patients with T3 and even T4 disease has increased with the publication of retrospective reports indicating long-term survival in patients with T3 and T4 tumors, 15 to 63 percent and 7 to 25 percent of patients, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/18,21,40,54,55,64,73-77\">",
"     18,21,40,54,55,64,73-77",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some groups advocate even more extensive resection involving hepatectomy, pancreaticoduodenectomy, colectomy, and even nephrectomy for patients with higher T stage but potentially resectable disease [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/54,55,78-84\">",
"     54,55,78-84",
"    </a>",
"    ]. Although long-term survivors are reported, morbidity and mortality rates are high (48 to 54, and 15 to 18 percent, respectively).",
"   </p>",
"   <p>",
"    For patients with regional nodal (N1 disease, limited to cystic, portal, and portocaval nodes) involvement, five-year survival rates from 28 to 60 percent are reported with radical resection [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/40,73,85\">",
"     40,73,85",
"    </a>",
"    ]. Results with radical lymphadenectomy are less favorable with N2 disease, particularly if the extent of nodal disease is beyond the hepatoduodenal ligament, posterosuperior pancreaticoduodenal area, and along the common hepatic artery [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/55,85\">",
"     55,85",
"    </a>",
"    ]. If preoperative fine needle aspiration confirms involvement of N2 nodes, the patient is not curable; thus, surgery should be performed only for palliation of specific problems. (See",
"    <a class=\"local\" href=\"#H1228877466\">",
"     'Palliative procedures'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In appropriately selected patients, the treatment of advanced but resectable gallbladder cancers (T3 disease) results in five-year survival rates ranging from 28 to 44 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/18,42\">",
"     18,42",
"    </a>",
"    ]. In a retrospective study of patients with incidentally discovered gallbladder cancer, patients with T3 disease who underwent re-resection had very high rates of residual disease found in any site (77 percent), in lymph node metastases (46 percent), and in the liver bed (36 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/17\">",
"     17",
"    </a>",
"    ]. Thus, patients with T3 tumors clearly warrant aggressive re-resection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H367086873\">",
"    <span class=\"h2\">",
"     Controversy over more aggressive resections",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with gallbladder that extends beyond the mucosa, &gt;T1a, the benefit of more radical surgery has been controversial. Randomized trials comparing simple cholecystectomy with radical surgery for gallbladder cancer have not been performed; all available studies are retrospective series. Some of these series, but not all, link better outcomes with more radical surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/21,32,54,55,80-84,86,87\">",
"     21,32,54,55,80-84,86,87",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In another Japanese series of 1686 resected gallbladder cancers from 172 major hospitals, survival rates were significantly better for patients undergoing radical resection compared with patients with simple cholecystectomy (three-year survival: 66 versus 14 percent, five-year survival: 51 versus 6 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      At the Mayo Clinic, 22 of 40 patients undergoing potentially curative resection had a simple cholecystectomy, while the remainder had a radical procedure [",
"      <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/87\">",
"       87",
"      </a>",
"      ]. Although five-year overall survival rates were similar (33 versus 32 percent), median survival in patients undergoing radical resection was significantly better (3.6 versus 0.8 years), and for those with transmural extension or nodal metastasis, the only five-year survivors were those who had undergone extended cholecystectomy.",
"     </li>",
"     <li>",
"      On the other hand, in a series of 104 patients treated at Memorial Sloan-Kettering over a 12-year period, major hepatectomy, resection of adjacent organs other than the liver, and common bile duct excision increased perioperative morbidity and were not associated with better survival [",
"      <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/83\">",
"       83",
"      </a>",
"      ]. The authors concluded that major hepatic resection (including excision of the common bile duct) was appropriate, when necessary, to clear disease, but not mandatory in all cases.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1159124143\">",
"    <span class=\"h2\">",
"     Managing an incidental gallbladder cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients undergoing cholecystectomy, unsuspected gallbladder cancer may be diagnosed based upon intraoperative findings or the final pathologic analysis. In three large series combined, incidental gallbladder cancer was found in 31 of 9497 patients undergoing laparoscopic cholecystectomy (0.33 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/11,13,14\">",
"     11,13,14",
"    </a>",
"    ]. The likelihood of finding a previously unsuspected gallbladder cancer during the course of open cholecystectomy is similar to that of laparoscopic cholecystectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H967658\">",
"    <span class=\"h3\">",
"     Identified by pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with patients with gallbladder cancer that is diagnosed preoperatively based upon imaging studies, the management of incidental gallbladder cancer depends upon disease extent (T stage) (",
"    <a class=\"graphic graphic_table graphicRef70554 \" href=\"UTD.htm?6/41/6813\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Most patients for whom a diagnosis of gallbladder cancer is made incidentally on postoperative gallbladder pathology will require a second procedure for curative intent because of a high rate of residual disease [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/2,17,18,50\">",
"     2,17,18,50",
"    </a>",
"    ]. This was illustrated in a series of 439 cases of incidentally found gallbladder cancer from a German registry (",
"    <a class=\"graphic graphic_table graphicRef71493 \" href=\"UTD.htm?26/44/27339\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/19\">",
"     19",
"    </a>",
"    ]. Most gallbladder cancers were T2 or higher and positive lymph nodes were found in 21 and 44 percent of the re-resected patients and T2 and T3 tumors. In these cases, re-resection is associated with significantly improved overall survival. Although re-resection is associated with additional risk, improvements in perioperative care and operative technique have decreased perioperative morbidity and mortality associated with major liver surgery in high-volume centers [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/31,88\">",
"     31,88",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H99390691\">",
"    <span class=\"h3\">",
"     Identified intraoperatively",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since the majority of cases of gallbladder cancer are not diagnosed intraoperatively, and, rather, are found incidentally during management of presumed benign gallbladder disease, it is important to have a plan for identifying and managing gallbladder cancer during the course of routine cholecystectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The surgeon should maintain a high index of suspicion for gallbladder cancer in patients with risk factors such as calcified (porcelain) gallbladder, gallbladder polyps, congenital biliary cysts, anomalous pancreaticobiliary junction, or longstanding chronic infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=see_link&amp;anchor=H3#H3\">",
"       \"Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis\", section on 'Risk factors'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If an obviously malignant lesion is encountered intraoperatively during laparoscopic cholecystectomy, it is best not to sample the lesion laparoscopically to reduce the hazard of seeding. The procedure should be converted to an open resection, if resection will be undertaken.",
"     </li>",
"     <li>",
"      Options for managing suspected gallbladder cancer include the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Completing the cholecystectomy and obtaining a frozen section of the suspicious area of the gallbladder. If the frozen section is positive for malignancy, extended cholecystectomy would be warranted. The indications to perform extrahepatic bile duct resection or lymph dissection are discussed below. (See",
"      <a class=\"local\" href=\"#H99392019\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For surgeons who are unfamiliar with more complex hepatobiliary surgery, closing the patient with or without simple cholecystectomy and referral to a high-volume center is appropriate. In a small retrospective review, no significant differences in survival were found comparing 6 patients who underwent immediate open conversion and radical resection with 33 patients who were referred to another center for resection [",
"      <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1159123618\">",
"    <span class=\"h1\">",
"     RESECTION TECHNIQUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical treatment of gallbladder cancer involves removal of the gallbladder with a margin of liver (except T1a disease) with or without regional lymph node or common bile duct resection. If frozen section analysis of the cystic duct stump is negative, a regional lymph node dissection is performed; if it is positive, then regional lymphadenectomy is undertaken along with extrahepatic bile duct resection. Resection of adherent involved adjacent organs may be necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The optimal surgical approach for patients diagnosed preoperatively, intraoperatively, or postoperatively is discussed in the preceding sections. The surgical techniques used to resect gallbladder cancer are the focus of this section. (See",
"    <a class=\"local\" href=\"#H99392019\">",
"     'Surgery'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H966975\">",
"    <span class=\"h2\">",
"     Cholecystectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gallbladder removal is a common and generally straightforward operation. Techniques for cholecystectomy (open or laparoscopic) are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/40/36489?source=see_link\">",
"     \"Open cholecystectomy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/4/11338?source=see_link\">",
"     \"Laparoscopic cholecystectomy: Techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Low stage (Tis, T1a) gallbladder cancers are curable with simple cholecystectomy. Higher-stage tumors will require, at least, extended cholecystectomy. When gallbladder cancer is suspected, an open approach is more often chosen to minimize the risk for bile spillage. (See",
"    <a class=\"local\" href=\"#H99392991\">",
"     'General approach'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Simple cholecystectomy may also be indicated in patients with more advanced disease as a palliative procedure to prevent future episodes of cholecystitis. In patients with locally unresectable disease, however, its value has not been definitely proven in this situation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H966253\">",
"    <span class=\"h2\">",
"     Extended cholecystectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients in whom a diagnosis of gallbladder cancer (&gt;T1a) has been made preoperatively, the gallbladder and a rim of liver are resected en bloc (extended cholecystectomy), which involves, at a minimum, the removal of at least a 2 cm margin of liver adjacent the gallbladder bed. A formal central liver resection may be appropriate depending upon the location of the tumor (fundus, body, neck).",
"   </p>",
"   <p>",
"    The margin of liver to be resected can be scored superficially (around the gallbladder and gallbladder mass) with electrocautery to a depth of a couple of millimeters, or sutures can be placed at each side of the margin of resection with absorbable sutures on a blunt needle. The gallbladder, tumor, and margin of liver are resected in a single en bloc specimen. Most studies demonstrate the importance of achieving negative margins (R0 resection) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/17,22,64,89-91\">",
"     17,22,64,89-91",
"    </a>",
"    ]. Standard techniques for liver resection are used with bleeding minimized by lowering central venous pressure during liver dissection and the use of topical hemostatic agents and surgical hemostatic devices.",
"   </p>",
"   <p>",
"    The cystic duct and cystic artery are identified by gentle retraction on the infundibulum of the gallbladder, and once it is clearly identified and dissected, each is ligated and divided. A sample of the cystic duct margin should be sent for frozen section [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/17\">",
"     17",
"    </a>",
"    ]. If the cystic duct margin is negative, portal lymphadenectomy should be performed. If the cystic duct margin is positive, bile duct resection (including portal and hepatoduodenal lymphadenectomy) and reconstruction are performed. Additional frozen sections will decide the need for further resection. Intraoperative frozen sections can reliably indicate whether tumor is present, they cannot reliably predict the depth of tumor invasion (T stage of the tumor) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/92\">",
"     92",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H604312644\">",
"     'Lymph node dissection'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H604313386\">",
"     'Bile duct resection'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    For patients with tumors of the fundus or body of the gallbladder, the tumor is generally far enough from the inflow structures to the liver to allow a margin-negative resection with at least 2 cm nonanatomic wedge resection of the gallbladder fossa, or anatomic resection of segment IVb and V [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/93\">",
"     93",
"    </a>",
"    ]. Various resection margins have been proposed, ranging from 1 to 5 cm, and none are solidly based on carefully collected data [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/94\">",
"     94",
"    </a>",
"    ]. There are no data from randomized trials showing a benefit for anatomic resection of segments IVb and V in patients with localized disease where a negative margin has otherwise been obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/95\">",
"     95",
"    </a>",
"    ]. Although a nonanatomic resection may provide a sufficient margin, an anatomic approach reduces the risk for bleeding or bile leakage [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/96\">",
"     96",
"    </a>",
"    ]. The pattern of drainage of the gallbladder veins may provide support for anatomic",
"    <span class=\"nowrap\">",
"     IVb/V",
"    </span>",
"    resection over nonanatomic resection. Veins from the gallbladder rarely enter the portal vein; rather, they drain into the middle hepatic vein via the cholecysto-hepatic veins [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/59,97\">",
"     59,97",
"    </a>",
"    ]. Direct lymphatic drainage into the liver has also been demonstrated. (See",
"    <a class=\"local\" href=\"#H738297\">",
"     'Gallbladder anatomy and physiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Right extended hemihepatectomy should be performed, if possible, for tumors of the body or neck of the gallbladder that involve the right portal triad or a scenario in which the porta hepatitis is involved with inflammation and the distinction between tumor and scar is obscured [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/84,98\">",
"     84,98",
"    </a>",
"    ]. Right extended hemihepatectomy increases the likelihood of achieving negative margins. In one study evaluating surgical margins, the distance between the front of the carcinoma and the resection plane ranged between 12 and 20 mm after wedge resection, 16 and 35 mm after resections of",
"    <span class=\"nowrap\">",
"     IVb/V,",
"    </span>",
"    and 28 and 58 mm after extended hepatic resection [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/99\">",
"     99",
"    </a>",
"    ]. Thus, some have advocated routine, right extended hemihepatectomy, or caudate lobe resection, regardless of hepatic involvement for these patients because of the improved likelihood of achieving negative margins and minimizing blood loss by resecting along anatomic planes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H604313386\">",
"    <span class=\"h2\">",
"     Bile duct resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the tumor extends into the common bile duct, or frozen section analysis of the cystic duct margin is positive, extrahepatic bile duct resection should be performed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/18,23,32,64,100\">",
"     18,23,32,64,100",
"    </a>",
"    ]. In a study of 115 patients who underwent surgery for gallbladder cancer, 42 percent of patients had residual disease in the common bile duct when the cystic duct stump had a positive margin on frozen section [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/17\">",
"     17",
"    </a>",
"    ]. Once a negative common hepatic duct margin is confirmed by frozen section, reconstruction is carried out with a Roux-en-Y hepaticojejunostomy (",
"    <a class=\"graphic graphic_figure graphicRef67421 \" href=\"UTD.htm?29/21/30036\">",
"     figure 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Some have advocated routine resection of the extrahepatic bile ducts, regardless of the result of the cystic duct stump frozen section, as a means to achieving a more complete lymphadenectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/101\">",
"     101",
"    </a>",
"    ]. However, several retrospective series have not shown a survival benefit for this approach in the management of gallbladder cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/2,17,102,103\">",
"     2,17,102,103",
"    </a>",
"    ]. Opponents of routine bile duct resection also cite the risk of potential, serious complications of hepaticojejunostomy, such as bile leak and anastomotic stricture [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/84,102\">",
"     84,102",
"    </a>",
"    ]. Further supporting this view, a retrospective study found that common duct resection does not necessarily yield a greater lymph node count [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the bile ducts do not need to be resected when the cystic duct margin is negative, the ducts may be compromised during skeletonization of the porta hepatis. If the ducts appear ischemic or otherwise injured, resection and reconstruction will become necessary. &nbsp;",
"   </p>",
"   <p>",
"    Intra-abdominal drains should be placed following resection and reconstruction of the extrahepatic bile ducts if oozing persists or bile leak is anticipated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H604312644\">",
"    <span class=\"h2\">",
"     Lymph node dissection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lymph node dissection is indicated if frozen section of the cystic duct margin is negative. In many cases, lymph node involvement is not obvious intraoperatively, and thus, even normal appearing nodes should be removed. Lymphatic metastases are found in 35 to 80 percent of patients with gallbladder tumors that invade the perimuscular connective tissue (&ge;T2) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/5,19-23,80,104\">",
"     5,19-23,80,104",
"    </a>",
"    ]. The lymphatic drainage of the gallbladder is presented above. (See",
"    <a class=\"local\" href=\"#H740004\">",
"     'Lymphatic drainage'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The extent of the lymphadenectomy is controversial. When lymph node resection is indicated, most experts advocate routine resection of lymph nodes of the porta hepatis and along the hepatoduodenal ligament. When regional node involvement is limited to cystic, portal, and portocaval nodes, five-year survival rates range from 28 to 60 percent with extended cholecystectomy and lymph node resection [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/73,85\">",
"     73,85",
"    </a>",
"    ]. Involvement of the celiac, peripancreatic, periduodenal, or superior mesenteric nodes is associated with significantly worse prognosis with few long-term survivors [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/21,55,75,85\">",
"     21,55,75,85",
"    </a>",
"    ]. Thus, most surgeons do not perform lymphadenectomy beyond the hepatoduodenal ligament.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H367097247\">",
"    <span class=\"h2\">",
"     Hepatic resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;More aggressive surgical management may include resection of other segments of the liver beyond that included in extended cholecystectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/105,106\">",
"     105,106",
"    </a>",
"    ]. Techniques for hepatic resection are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24569?source=see_link\">",
"     \"Hepatic resection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H90813616\">",
"    <span class=\"h2\">",
"     Laparoscopic port site resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although available data suggest that laparoscopic manipulation does not diminish the survival of patients with incidentally found GBC, port site recurrences have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/45,107-110\">",
"     45,107-110",
"    </a>",
"    ]. Although some have recommended port site excision at the time of reexploration [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/13,16\">",
"     13,16",
"    </a>",
"    ], radical resection does not require resection of the previous laparoscopy port sites [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/32,110\">",
"     32,110",
"    </a>",
"    ]. If tumor is found in the port sites, this is a marker for peritoneal disease and removal of the port sites will not be curative.",
"   </p>",
"   <p>",
"    In a study of 113 patients with GBC detected incidentally at laparoscopic cholecystectomy, 69 had port site resection at the time of reexploration and 44 did not [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/110\">",
"     110",
"    </a>",
"    ]. Port site disease was seen only in patients with T2 or T3 disease and correlated with the development of peritoneal metastases. Port site resection was not associated with overall survival or recurrence-free survival. The authors do not recommend port site resections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1228877466\">",
"    <span class=\"h1\">",
"     PALLIATIVE PROCEDURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with unresectable gallbladder cancer may develop jaundice, upper abdominal pain, and symptoms of biliary obstruction. The optimal palliative therapy provides relief of symptoms with minimal perioperative morbidity and mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/66\">",
"     66",
"    </a>",
"    ]. The choice of palliative procedure depends upon the nature of obstructive symptoms and an assessment of medical risk associated with the procedure.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Simple cholecystectomy",
"     </li>",
"     <li>",
"      Endoscopic or percutaneous biliary drainage &ndash; (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8186?source=see_link\">",
"       \"Endoscopic stenting for malignant pancreaticobiliary obstruction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Endoscopic stenting or intestinal bypass &ndash; (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/0/37895?source=see_link\">",
"       \"Enteral stents for the palliation of malignant gastroduodenal obstruction\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14058?source=see_link\">",
"       \"Small bowel obstruction: Causes and management\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Biliary bypass &ndash; Another option in patients who can tolerate surgery is biliary bypass, but many patients fail these procedures with recurrent obstruction as the disease progresses. In one study, intrahepatic segment III cholangiojejunostomy and staying away from the hepatoduodenal ligament, the most common site of disease progression, successfully palliated the majority of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/80\">",
"       80",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H111057050\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Morbidity and mortality rates from resection for gallbladder cancer vary widely, with major morbidity rates ranging from 5 to 54 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/21,54,55,111\">",
"     21,54,55,111",
"    </a>",
"    ], and perioperative mortality rates from 0 to 21 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/21,54,56,64,72,74,111-115\">",
"     21,54,56,64,72,74,111-115",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common complications following resection for gallbladder cancer are the same as other hepatobiliary surgeries, such as postoperative bleeding, bile leak, and perihepatic abscess.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H971879\">",
"    <span class=\"h2\">",
"     Perioperative mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perioperative mortality (30-day) rates increase with more extensive resection. In one report of 1686 resections for GBC from Japan, perioperative mortality for extended cholecystectomy, hepatic lobectomy, and hepatopancreatoduodenectomy were 2.3, 17.9, and 15.3 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The nonspecificity of symptoms and advanced stage of disease at presentation are reflected in the poor outcomes reported in most series for gallbladder cancer. Five-year survival rates are 5 to 12 percent in many large series [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/72,116,117\">",
"     72,116,117",
"    </a>",
"    ]. Long-term outcomes are relatively poor for any stage of disease beyond T1N0 (",
"    <a class=\"graphic graphic_table graphicRef70554 \" href=\"UTD.htm?6/41/6813\">",
"     table 1",
"    </a>",
"    ). Unfortunately, fewer than 10 percent of patients who present with symptoms have T1 tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/118,119\">",
"     118,119",
"    </a>",
"    ], whereas about 20 percent of patients with incidentally diagnosed gallbladder have T1 tumors (",
"    <a class=\"graphic graphic_table graphicRef71493 \" href=\"UTD.htm?26/44/27339\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/12/22730/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Long-term prognosis, recurrence and adjuvant therapy for the treatment of gallbladder cancer are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/24/43399?source=see_link&amp;anchor=H16#H16\">",
"     \"Adjuvant treatment for localized, potentially resectable gallbladder cancer\", section on 'Benefits of adjuvant therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/31/4595?source=see_link\">",
"       \"Patient information: Gallbladder cancer (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H111053273\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Surgery is the only potentially curative treatment for gallbladder cancer. Surgical series report long-term survival rates of 85 to 100 percent for patients with early-stage (T1) disease. Unfortunately, fewer than 10 percent of symptomatic patients and only about 20 percent of patients with incidentally diagnosed gallbladder cancer have early-stage disease. The poor prognosis associated with GBC is related to the often advanced stage at diagnosis. (See",
"      <a class=\"local\" href=\"#H111050694\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H971879\">",
"       'Perioperative mortality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Staging prior to considering resection is important and can be accomplished using a combination of preoperative imaging and diagnostic laparoscopy to rule out locally unresectable or metastatic disease. The risk of distant metastases increases as T stage increases. Current imaging remains insensitive in the detection of peritoneal disease. (See",
"      <a class=\"local\" href=\"#H1159119845\">",
"       'Staging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with a preoperative diagnosis of potentially resectable, localized gallbladder cancer should be offered definitive resection which involves en bloc resection of the gallbladder and a margin of underlying liver (nonanatomic or anatomic resection), and resection of the regional lymph nodes or extrahepatic biliary ducts depending upon the extent of disease identified intraoperatively. A right hepatic lobectomy may be appropriate in selected patients (eg, tumor of the gallbladder neck, tumor involving the right portal triad). (See",
"      <a class=\"local\" href=\"#H1159123618\">",
"       'Resection techniques'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who are diagnosed with gallbladder cancer previously unsuspected at the time of cholecystectomy, we recommend exploration and re-resection if disease extent is stage T2 or higher (",
"      <a class=\"graphic graphic_table graphicRef70554 \" href=\"UTD.htm?6/41/6813\">",
"       table 1",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). The benefit of reexploration for patients with incidentally diagnosed T1 disease is more controversial. However, we suggest reexploration for fit patients with T1b disease (tumor invading the muscularis layer), but not for T1a disease (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1159124143\">",
"       'Managing an incidental gallbladder cancer'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/1\">",
"      Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol 2008; 98:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/2\">",
"      Shih SP, Schulick RD, Cameron JL, et al. Gallbladder cancer: the role of laparoscopy and radical resection. Ann Surg 2007; 245:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/3\">",
"      Cavallaro A, Piccolo G, Panebianco V, et al. Incidental gallbladder cancer during laparoscopic cholecystectomy: managing an unexpected finding. World J Gastroenterol 2012; 18:4019.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/4\">",
"      Miller G, Jarnagin WR. Gallbladder carcinoma. Eur J Surg Oncol 2008; 34:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/5\">",
"      Pilgrim CH, Usatoff V, Evans P. Consideration of anatomical structures relevant to the surgical strategy for managing gallbladder carcinoma. Eur J Surg Oncol 2009; 35:1131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/6\">",
"      Shirai Y, Yoshida K, Tsukada K, et al. Identification of the regional lymphatic system of the gallbladder by vital staining. Br J Surg 1992; 79:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/7\">",
"      Uesaka K, Yasui K, Morimoto T, et al. Visualization of routes of lymphatic drainage of the gallbladder with a carbon particle suspension. J Am Coll Surg 1996; 183:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/8\">",
"      Ito M, Mishima Y, Sato T. An anatomical study of the lymphatic drainage of the gallbladder. Surg Radiol Anat 1991; 13:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/9\">",
"      Terazawa T, Miyake H, Kurahashi M, Tashiro S. Direct lymphatic spreading route into the liver from the gallbladder: an animal experiment using pig. J Med Invest 2004; 51:210.",
"     </a>",
"    </li>",
"    <li>",
"     American Joint Committee on Cancer Staging Manual, 7th, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2010. p.211.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/11\">",
"      Konstantinidis IT, Deshpande V, Genevay M, et al. Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg 2009; 144:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/12\">",
"      Varshney S, Butturini G, Buttirini G, Gupta R. Incidental carcinoma of the gallbladder. Eur J Surg Oncol 2002; 28:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/13\">",
"      Yamaguchi K, Chijiiwa K, Ichimiya H, et al. Gallbladder carcinoma in the era of laparoscopic cholecystectomy. Arch Surg 1996; 131:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/14\">",
"      A prospective analysis of 1518 laparoscopic cholecystectomies. The Southern Surgeons Club. N Engl J Med 1991; 324:1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/15\">",
"      Antonakis P, Alexakis N, Mylonaki D, et al. Incidental finding of gallbladder carcinoma detected during or after laparoscopic cholecystectomy. Eur J Surg Oncol 2003; 29:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/16\">",
"      Giuliante F, Ardito F, Vellone M, et al. Port-sites excision for gallbladder cancer incidentally found after laparoscopic cholecystectomy. Am J Surg 2006; 191:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/17\">",
"      Pawlik TM, Gleisner AL, Vigano L, et al. Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg 2007; 11:1478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/18\">",
"      Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 2000; 232:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/19\">",
"      Goetze TO, Paolucci V. Benefits of reoperation of T2 and more advanced incidental gallbladder carcinoma: analysis of the German registry. Ann Surg 2008; 247:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/20\">",
"      Tsukada K, Hatakeyama K, Kurosaki I, et al. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery 1996; 120:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/21\">",
"      Bartlett DL, Fong Y, Fortner JG, et al. Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg 1996; 224:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/22\">",
"      de Aretxabala X, Roa I, Burgos L, et al. Gallbladder cancer in Chile. A report on 54 potentially resectable tumors. Cancer 1992; 69:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/23\">",
"      Fong Y, Heffernan N, Blumgart LH. Gallbladder carcinoma discovered during laparoscopic cholecystectomy: aggressive reresection is beneficial. Cancer 1998; 83:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/24\">",
"      Mekeel KL, Hemming AW. Surgical management of gallbladder carcinoma: a review. J Gastrointest Surg 2007; 11:1188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/25\">",
"      Levy AD, Murakata LA, Rohrmann CA Jr. Gallbladder carcinoma: radiologic-pathologic correlation. Radiographics 2001; 21:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/26\">",
"      Corvera CU, Blumgart LH, Akhurst T, et al. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg 2008; 206:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/27\">",
"      Anderson CD, Rice MH, Pinson CW, et al. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 2004; 8:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/28\">",
"      Weber SM, DeMatteo RP, Fong Y, et al. Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients. Ann Surg 2002; 235:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/29\">",
"      Butte JM, G&ouml;nen M, Allen PJ, et al. The role of laparoscopic staging in patients with incidental gallbladder cancer. HPB (Oxford) 2011; 13:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/30\">",
"      Gaujoux S, Allen PJ. Role of staging laparoscopy in peri-pancreatic and hepatobiliary malignancy. World J Gastrointest Surg 2010; 2:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/31\">",
"      Shoup M, Fong Y. Surgical indications and extent of resection in gallbladder cancer. Surg Oncol Clin N Am 2002; 11:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/32\">",
"      Jayaraman S, Jarnagin WR. Management of gallbladder cancer. Gastroenterol Clin North Am 2010; 39:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/33\">",
"      Foster JM, Hoshi H, Gibbs JF, et al. Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection. Ann Surg Oncol 2007; 14:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/34\">",
"      Matthews JB. Planned laparoscopic approach for early-stage gallbladder cancer: the glass is one-third full. Arch Surg 2010; 145:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/35\">",
"      Weiland ST, Mahvi DM, Niederhuber JE, et al. Should suspected early gallbladder cancer be treated laparoscopically? J Gastrointest Surg 2002; 6:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/36\">",
"      Ricardo AE, Feig BW, Ellis LM, et al. Gallbladder cancer and trocar site recurrences. Am J Surg 1997; 174:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/37\">",
"      Wullstein C, Woeste G, Barkhausen S, et al. Do complications related to laparoscopic cholecystectomy influence the prognosis of gallbladder cancer? Surg Endosc 2002; 16:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/38\">",
"      Reddy YP, Sheridan WG. Port-site metastasis following laparoscopic cholecystectomy: a review of the literature and a case report. Eur J Surg Oncol 2000; 26:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/39\">",
"      Cho JY, Han HS, Yoon YS, et al. Laparoscopic approach for suspected early-stage gallbladder carcinoma. Arch Surg 2010; 145:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/40\">",
"      Shirai Y, Yoshida K, Tsukada K, Muto T. Inapparent carcinoma of the gallbladder. An appraisal of a radical second operation after simple cholecystectomy. Ann Surg 1992; 215:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/41\">",
"      de Aretxabala XA, Roa IS, Burgos LA, et al. Curative resection in potentially resectable tumours of the gallbladder. Eur J Surg 1997; 163:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/42\">",
"      Shirai Y, Yoshida K, Tsukada K, et al. Early carcinoma of the gallbladder. Eur J Surg 1992; 158:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/43\">",
"      Wakai T, Shirai Y, Yokoyama N, et al. Early gallbladder carcinoma does not warrant radical resection. Br J Surg 2001; 88:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/44\">",
"      Yamaguchi K, Tsuneyoshi M. Subclinical gallbladder carcinoma. Am J Surg 1992; 163:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/45\">",
"      Suzuki K, Kimura T, Ogawa H. Long-term prognosis of gallbladder cancer diagnosed after laparoscopic cholecystectomy. Surg Endosc 2000; 14:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/46\">",
"      Sun CD, Zhang BY, Wu LQ, Lee WJ. Laparoscopic cholecystectomy for treatment of unexpected early-stage gallbladder cancer. J Surg Oncol 2005; 91:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/47\">",
"      Yoshida T, Matsumoto T, Sasaki A, et al. Laparoscopic cholecystectomy in the treatment of patients with gall bladder cancer. J Am Coll Surg 2000; 191:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/48\">",
"      Yildirim E, Celen O, Gulben K, Berberoglu U. The surgical management of incidental gallbladder carcinoma. Eur J Surg Oncol 2005; 31:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/49\">",
"      Kapoor VK, Haribhakti SP. Extended cholecystectomy for carcinoma of the gall bladder. Trop Gastroenterol 1995; 16:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/50\">",
"      Ouchi K, Mikuni J, Kakugawa Y, Organizing Committee, The 30th Annual Congress of the Japanese Society of Biliary Surgery. Laparoscopic cholecystectomy for gallbladder carcinoma: results of a Japanese survey of 498 patients. J Hepatobiliary Pancreat Surg 2002; 9:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/51\">",
"      Taner CB, Nagorney DM, Donohue JH. Surgical treatment of gallbladder cancer. J Gastrointest Surg 2004; 8:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/52\">",
"      Coburn NG, Cleary SP, Tan JC, Law CH. Surgery for gallbladder cancer: a population-based analysis. J Am Coll Surg 2008; 207:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/53\">",
"      You DD, Lee HG, Paik KY, et al. What is an adequate extent of resection for T1 gallbladder cancers? Ann Surg 2008; 247:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/54\">",
"      Matsumoto Y, Fujii H, Aoyama H, et al. Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens. Am J Surg 1992; 163:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/55\">",
"      Ogura Y, Mizumoto R, Isaji S, et al. Radical operations for carcinoma of the gallbladder: present status in Japan. World J Surg 1991; 15:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/56\">",
"      Ouchi K, Suzuki M, Tominaga T, et al. Survival after surgery for cancer of the gallbladder. Br J Surg 1994; 81:1655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/57\">",
"      Abramson MA, Pandharipande P, Ruan D, et al. Radical resection for T1b gallbladder cancer: a decision analysis. HPB (Oxford) 2009; 11:656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/58\">",
"      Muratore A, Polastri R, Bouzari H, et al. Radical surgery for gallbladder cancer: a worthwhile operation? Eur J Surg Oncol 2000; 26:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/59\">",
"      Ouchi K, Owada Y, Matsuno S, Sato T. Prognostic factors in the surgical treatment of gallbladder carcinoma. Surgery 1987; 101:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/60\">",
"      Wright BE, Lee CC, Iddings DM, et al. Management of T2 gallbladder cancer: are practice patterns consistent with national recommendations? Am J Surg 2007; 194:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/61\">",
"      Shimada H, Endo I, Togo S, et al. The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer 1997; 79:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/62\">",
"      Kapoor VK. Incidental gallbladder cancer. Am J Gastroenterol 2001; 96:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/63\">",
"      Ouchi K, Suzuki M, Saijo S, et al. Do recent advances in diagnosis and operative management improve the outcome of gallbladder carcinoma? Surgery 1993; 113:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/64\">",
"      Gall FP, K&ouml;ckerling F, Scheele J, et al. Radical operations for carcinoma of the gallbladder: present status in Germany. World J Surg 1991; 15:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/65\">",
"      Yokomizo H, Yamane T, Hirata T, et al. Surgical treatment of pT2 gallbladder carcinoma: a reevaluation of the therapeutic effect of hepatectomy and extrahepatic bile duct resection based on the long-term outcome. Ann Surg Oncol 2007; 14:1366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/66\">",
"      Oertli D, Herzog U, Tondelli P. Primary carcinoma of the gallbladder: operative experience during a 16 year period. Eur J Surg 1993; 159:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/67\">",
"      Paquet KJ. Appraisal of surgical resection of gallbladder carcinoma with special reference to hepatic resection. J Hepatobiliary Pancreat Surg 1998; 5:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/68\">",
"      Chijiiwa K, Nakano K, Ueda J, et al. Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer. J Am Coll Surg 2001; 192:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/69\">",
"      Toyonaga T, Chijiiwa K, Nakano K, et al. Completion radical surgery after cholecystectomy for accidentally undiagnosed gallbladder carcinoma. World J Surg 2003; 27:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/70\">",
"      Downing SR, Cadogan KA, Ortega G, et al. Early-stage gallbladder cancer in the Surveillance, Epidemiology, and End Results database: effect of extended surgical resection. Arch Surg 2011; 146:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/71\">",
"      Ito H, Ito K, D'Angelica M, et al. Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Ann Surg 2011; 254:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/72\">",
"      Cubertafond P, Mathonnet M, Gainant A, Launois B. Radical surgery for gallbladder cancer. Results of the French Surgical Association Survey. Hepatogastroenterology 1999; 46:1567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/73\">",
"      Yamamoto M, Onoyama H, Ajiki T, et al. Surgical results of operations for carcinoma of the gallbladder. Hepatogastroenterology 1999; 46:1552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/74\">",
"      Nimura Y, Hayakawa N, Kamiya J, et al. Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract. Hepatogastroenterology 1991; 38:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/75\">",
"      Benoist S, Panis Y, Fagniez PL. Long-term results after curative resection for carcinoma of the gallbladder. French University Association for Surgical Research. Am J Surg 1998; 175:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/76\">",
"      Nakamura S, Suzuki S, Konno H, et al. Outcome of extensive surgery for TNM stage IV carcinoma of the gallbladder. Hepatogastroenterology 1999; 46:2138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/77\">",
"      Kayahara M, Nagakawa T. Recent trends of gallbladder cancer in Japan: an analysis of 4,770 patients. Cancer 2007; 110:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/78\">",
"      Gagner M, Rossi RL. Radical operations for carcinoma of the gallbladder: present status in North America. World J Surg 1991; 15:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/79\">",
"      Donohue JH, Stewart AK, Menck HR. The National Cancer Data Base report on carcinoma of the gallbladder, 1989-1995. Cancer 1998; 83:2618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/80\">",
"      Kapoor VK, Pradeep R, Haribhakti SP, et al. Intrahepatic segment III cholangiojejunostomy in advanced carcinoma of the gallbladder. Br J Surg 1996; 83:1709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/81\">",
"      Dixon E, Vollmer CM Jr, Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg 2005; 241:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/82\">",
"      Tashiro S, Konno T, Mochinaga M, et al. Treatment of carcinoma of the gallbladder in Japan. Jpn J Surg 1982; 12:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/83\">",
"      D'Angelica M, Dalal KM, DeMatteo RP, et al. Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol 2009; 16:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/84\">",
"      Sikora SS, Singh RK. Surgical strategies in patients with gallbladder cancer: nihilism to optimism. J Surg Oncol 2006; 93:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/85\">",
"      Chijiiwa K, Noshiro H, Nakano K, et al. Role of surgery for gallbladder carcinoma with special reference to lymph node metastasis and stage using western and Japanese classification systems. World J Surg 2000; 24:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/86\">",
"      Costi R, Violi V, Roncoroni L, Sarli L. Gallbladder cancer and radical surgery. Ann Surg 2008; 248:494; author reply 495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/87\">",
"      Donohue JH, Nagorney DM, Grant CS, et al. Carcinoma of the gallbladder. Does radical resection improve outcome? Arch Surg 1990; 125:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/88\">",
"      Wakai T, Shirai Y, Hatakeyama K. Radical second resection provides survival benefit for patients with T2 gallbladder carcinoma first discovered after laparoscopic cholecystectomy. World J Surg 2002; 26:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/89\">",
"      Bloechle C, Izbicki JR, Passlick B, et al. Is radical surgery in locally advanced gallbladder carcinoma justified? Am J Gastroenterol 1995; 90:2195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/90\">",
"      Todoroki T, Kawamoto T, Takahashi H, et al. Treatment of gallbladder cancer by radical resection. Br J Surg 1999; 86:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/91\">",
"      Behari A, Sikora SS, Wagholikar GD, et al. Longterm survival after extended resections in patients with gallbladder cancer. J Am Coll Surg 2003; 196:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/92\">",
"      Yamaguchi K, Chijiiwa K, Saiki S, et al. Reliability of frozen section diagnosis of gallbladder tumor for detecting carcinoma and depth of its invasion. J Surg Oncol 1997; 65:132.",
"     </a>",
"    </li>",
"    <li>",
"     Blumgart LH. Surgery of the Liver, Biliary Tract and Pancreas, 4th edition, Saunders, Philadelphia 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/94\">",
"      Endo I, Shimada H, Takimoto A, et al. Microscopic liver metastasis: prognostic factor for patients with pT2 gallbladder carcinoma. World J Surg 2004; 28:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/95\">",
"      Sicklick JK, Choti MA. Controversies in the surgical management of cholangiocarcinoma and gallbladder cancer. Semin Oncol 2005; 32:S112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/96\">",
"      Scheingraber S, Justinger C, Stremovskaia T, et al. The standardized surgical approach improves outcome of gallbladder cancer. World J Surg Oncol 2007; 5:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/97\">",
"      Misra MC, Guleria S. Management of cancer gallbladder found as a surprise on a resected gallbladder specimen. J Surg Oncol 2006; 93:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/98\">",
"      Bartlett DL. Gallbladder cancer. Semin Surg Oncol 2000; 19:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/99\">",
"      Ogura Y, Tabata M, Kawarada Y, Mizumoto R. Effect of hepatic invasion on the choice of hepatic resection for advanced carcinoma of the gallbladder: histologic analysis of 32 surgical cases. World J Surg 1998; 22:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/100\">",
"      Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003; 4:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/101\">",
"      Shimizu Y, Ohtsuka M, Ito H, et al. Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer? Surgery 2004; 136:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/102\">",
"      Kosuge T, Sano K, Shimada K, et al. Should the bile duct be preserved or removed in radical surgery for gallbladder cancer? Hepatogastroenterology 1999; 46:2133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/103\">",
"      Chijiiwa K, Tanaka M. Indications for and limitations of extended cholecystectomy in the treatment of carcinoma of the gall bladder. Eur J Surg 1996; 162:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/104\">",
"      Muratore A, Polastri R, Capussotti L. Radical surgery for gallbladder cancer: current options. Eur J Surg Oncol 2000; 26:438.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/105\">",
"      Shimada K, Nara S, Esaki M, et al. Extended right hemihepatectomy for gallbladder carcinoma involving the hepatic hilum. Br J Surg 2011; 98:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/106\">",
"      Reddy SK, Marroquin CE, Kuo PC, et al. Extended hepatic resection for gallbladder cancer. Am J Surg 2007; 194:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/107\">",
"      Steinert R, Nestler G, Sagynaliev E, et al. Laparoscopic cholecystectomy and gallbladder cancer. J Surg Oncol 2006; 93:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/108\">",
"      Whalen GF, Bird I, Tanski W, et al. Laparoscopic cholecystectomy does not demonstrably decrease survival of patients with serendipitously treated gallbladder cancer. J Am Coll Surg 2001; 192:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/109\">",
"      Lundberg O, Kristoffersson A. Port site metastases from gallbladder cancer after laparoscopic cholecystectomy. Results of a Swedish survey and review of published reports. Eur J Surg 1999; 165:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/110\">",
"      Maker AV, Butte JM, Oxenberg J, et al. Is port site resection necessary in the surgical management of gallbladder cancer? Ann Surg Oncol 2012; 19:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/111\">",
"      Nakamura S, Sakaguchi S, Suzuki S, Muro H. Aggressive surgery for carcinoma of the gallbladder. Surgery 1989; 106:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/112\">",
"      Butte JM, Matsuo K, G&ouml;nen M, et al. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg 2011; 212:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/113\">",
"      Nakeeb A, Tran KQ, Black MJ, et al. Improved survival in resected biliary malignancies. Surgery 2002; 132:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/114\">",
"      Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey. Ann Surg 1994; 219:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/115\">",
"      Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 2003; 98:1689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/116\">",
"      Wilkinson DS. Carcinoma of the gall-bladder: an experience and review of the literature. Aust N Z J Surg 1995; 65:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/117\">",
"      Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995; 75:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/118\">",
"      Fong Y, Wagman L, Gonen M, et al. Evidence-based gallbladder cancer staging: changing cancer staging by analysis of data from the National Cancer Database. Ann Surg 2006; 243:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/12/22730/abstract/119\">",
"      Kiran RP, Pokala N, Dudrick SJ. Incidence pattern and survival for gallbladder cancer over three decades--an analysis of 10301 patients. Ann Surg Oncol 2007; 14:827.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15097 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-B1BE4F5CD0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22730=[""].join("\n");
var outline_f22_12_22730=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H111053273\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H111050694\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H738297\">",
"      GALLBLADDER ANATOMY AND PHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H740004\">",
"      Lymphatic drainage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H741641\">",
"      CLINICAL SCENARIOS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1159119845\">",
"      STAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1159123350\">",
"      Preoperative imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1159123466\">",
"      Diagnostic staging laparoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H99392790\">",
"      CONTRAINDICATIONS TO RESECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H99392019\">",
"      SURGERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H99392991\">",
"      General approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1228870938\">",
"      Cholecystectomy versus extended cholecystectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H111058036\">",
"      - T1 gallbladder cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H111058043\">",
"      - T2 gallbladder cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1228870927\">",
"      - Resectable T3/4 or node positive gallbladder cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H367086873\">",
"      Controversy over more aggressive resections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1159124143\">",
"      Managing an incidental gallbladder cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H967658\">",
"      - Identified by pathology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H99390691\">",
"      - Identified intraoperatively",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1159123618\">",
"      RESECTION TECHNIQUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H966975\">",
"      Cholecystectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H966253\">",
"      Extended cholecystectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H604313386\">",
"      Bile duct resection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H604312644\">",
"      Lymph node dissection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H367097247\">",
"      Hepatic resection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H90813616\">",
"      Laparoscopic port site resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1228877466\">",
"      PALLIATIVE PROCEDURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H111057050\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H971879\">",
"      Perioperative mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H111053273\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/15097\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15097|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/48/15106\" title=\"figure 1\">",
"      Gallbladder anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?13/35/13878\" title=\"figure 2\">",
"      Segmental anatomy of liver",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/10/6307\" title=\"figure 3\">",
"      Variations in the cystic and hepatic ducts",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/3/18481\" title=\"figure 4\">",
"      Variations in the origin and course of the cystic artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/21/30036\" title=\"figure 5\">",
"      Biliary reconstruction with Roux-en-Y hepaticojejunostomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15097|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/41/6813\" title=\"table 1\">",
"      TNM staging gallbladder CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/44/27339\" title=\"table 2\">",
"      Stage distribution for gallbladder cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/24/43399?source=related_link\">",
"      Adjuvant treatment for localized, potentially resectable gallbladder cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/39/15992?source=related_link\">",
"      Diagnostic staging laparoscopy: General principles for staging primary digestive malignancies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/63/8186?source=related_link\">",
"      Endoscopic stenting for malignant pancreaticobiliary obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/0/37895?source=related_link\">",
"      Enteral stents for the palliation of malignant gastroduodenal obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/46/15082?source=related_link\">",
"      Gallbladder cancer: Epidemiology, risk factors, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24569?source=related_link\">",
"      Hepatic resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/4/11338?source=related_link\">",
"      Laparoscopic cholecystectomy: Techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/40/36489?source=related_link\">",
"      Open cholecystectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/31/4595?source=related_link\">",
"      Patient information: Gallbladder cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/51/35638?source=related_link\">",
"      Physiology of cholecystokinin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30265?source=related_link\">",
"      Principles of abdominal wall incisions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14058?source=related_link\">",
"      Small bowel obstruction: Causes and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/11/33977?source=related_link\">",
"      Treatment of advanced, unresectable gallbladder cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/33/25114?source=related_link\">",
"      Treatment of localized cholangiocarcinoma: Surgical management and adjuvant therapy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_12_22731="Psychosoc issues thal present";
var content_f22_12_22731=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F76407&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F76407&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Psychosocial burden of thalassemia in the present",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Better physical appearance",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pubertal growth and sexual development",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Schooling",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Working",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Establishing relationships",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Getting married",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Raising a family",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Low compliance with treatment for large number of patients",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Living for today",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Denial/anxiety/hostility",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Prospects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Oral chelators",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HbF inducers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone marrow transplantation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gene therapy",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Politis, C. The psychosocial impact of chronic illness. Cooley's anemia, Seventh Symposium. Ann N Y Acad Sci 1998; 850:349.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22731=[""].join("\n");
var outline_f22_12_22731=null;
var title_f22_12_22732="NKPI for extranodal NK-T cell lymphoma nasal type";
var content_f22_12_22732=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F67924&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F67924&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    NK/T cell lymphoma prognostic index (NKPI) for extranodal NK/T cell lymphoma, nasal type",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td colspan=\"3\">",
"        Presence of systemic B symptoms*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Ann Arbor stage III or IV disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Elevated lactate dehydrogenase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"3\">",
"        Regional lymph node involvement",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td colspan=\"3\">",
"        One point is given for each of the above characteristics present in the patient, for a total score ranging from zero to four. When applied to retrospective series of patients with extranodal NK/T cell lymphoma, five-year overall survival (OS) and rates of central nervous system (CNS) involvement without prophylaxis according to score were as follows:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Score",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        OS, percent",
"        <sup>",
"         [1]",
"        </sup>",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        CNS involvement, percent",
"        <sup>",
"         [2]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0",
"       </td>",
"       <td>",
"        81",
"       </td>",
"       <td>",
"        &lt;2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        64",
"       </td>",
"       <td>",
"        &lt;2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        34",
"       </td>",
"       <td>",
"        &lt;2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3 or 4",
"       </td>",
"       <td>",
"        7",
"       </td>",
"       <td>",
"        10",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Systemic B symptoms are defined as temperature &gt;38&deg;C (&gt;100.4&deg;F), unexplained weight loss of &gt;10 percent of body weight over the past six months, and/or the presence of drenching night sweats.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Regional lymph node involvement was defined as the invasion of lymph nodes corresponding to N1, N2, or N3 of the primary lesion in the American Joint Committee on Cancer tumor (T), nodes (N), metastasis (M) staging system. An example of regional lymph node involvement is the involvement of cervical nodes for patients with NK/T cell lymphoma of the upper aerodigestive tract.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Lee J, Suh C, Park YH, et al. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006; 24:612.",
"       </li>",
"       <li>",
"        Kim SJ, Oh SY, Hong JY. When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type? Ann Oncol 2010; 21:1058.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22732=[""].join("\n");
var outline_f22_12_22732=null;
var title_f22_12_22733="Rx inflammatory bowel";
var content_f22_12_22733=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F56444&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F56444&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Aminosalicylate derivative dosages* for active disease and remission maintenance in ulcerative colitis and Crohn's disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Release of active compound",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Ulcerative colitis",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Crohn's colitis",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Crohn's ileitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Active",
"       </td>",
"       <td class=\"subtitle2\">",
"        Maint",
"       </td>",
"       <td class=\"subtitle2\">",
"        Active",
"       </td>",
"       <td class=\"subtitle2\">",
"        Maint",
"       </td>",
"       <td class=\"subtitle2\">",
"        Active",
"       </td>",
"       <td class=\"subtitle2\">",
"        Maint",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sulfasalazine [tablet, enteric-coated delayed release tablet]",
"       </td>",
"       <td>",
"        Converted to mesalamine in colon",
"       </td>",
"       <td>",
"        2-4",
"       </td>",
"       <td>",
"        2-4",
"       </td>",
"       <td>",
"        2-4",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        ID",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Asacol&reg;, Asacol HD&reg; [mesalamine tablet, delayed release]",
"       </td>",
"       <td>",
"        Release is delayed until terminal ileum and cecum, then releases as bolus in right colon.",
"       </td>",
"       <td>",
"        2.4-4.8",
"       </td>",
"       <td>",
"        2.4-4.8",
"       </td>",
"       <td>",
"        2.4-4.8",
"       </td>",
"       <td>",
"        2.4-4.8",
"       </td>",
"       <td>",
"        2.4-4.8",
"       </td>",
"       <td>",
"        2.4-4.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pentasa&reg; [mesalamine capsule, extended release]",
"       </td>",
"       <td>",
"        Prolonged release throughout duodenum, jejunum, ileum, and colon. Fifty percent released in small bowel.",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        2-4",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        2-4",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        2-4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dipentum&reg; [olsalazine capsule]",
"       </td>",
"       <td>",
"        Converted to mesalamine in colon",
"       </td>",
"       <td>",
"        2-3",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        2-3",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rowasa&reg;, sfRowasa&trade; [mesalamine rectal enema]",
"       </td>",
"       <td>",
"        Sigmoid colon, rectum",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        2-4",
"       </td>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        ID",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Apriso&trade; [mesalamine capsule, 24 hour delayed and extended release]",
"       </td>",
"       <td>",
"        Release occurs at pH &ge;6, then prolonged throughout colon.",
"       </td>",
"       <td>",
"        1.5-3",
"       </td>",
"       <td>",
"        1.5",
"       </td>",
"       <td>",
"        ID",
"       </td>",
"       <td>",
"        ID",
"       </td>",
"       <td>",
"        ID",
"       </td>",
"       <td>",
"        ID",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lialda&reg;, Mezavant&reg;, Mezavant XL&reg; [mesalamine multi-maxtrix (MMX) tablet, 24 hour release]",
"       </td>",
"       <td>",
"        Release is delayed until terminal ileum, then designed to release throughout colon, including sigmoid colon and rectum.",
"       </td>",
"       <td>",
"        2.4-4.8",
"       </td>",
"       <td>",
"        2.4",
"       </td>",
"       <td>",
"        ID",
"       </td>",
"       <td>",
"        ID",
"       </td>",
"       <td>",
"        ID",
"       </td>",
"       <td>",
"        ID",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Canasa&reg; [mesalamine rectal suppository]",
"       </td>",
"       <td>",
"        Rectum",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        ID",
"       </td>",
"       <td>",
"        ID",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Colazal&reg; [balsalazide disodium capsule]",
"       </td>",
"       <td>",
"        Converted to mesalamine in colon",
"       </td>",
"       <td>",
"        6.75",
"       </td>",
"       <td>",
"        3-6",
"       </td>",
"       <td>",
"        ID",
"       </td>",
"       <td>",
"        ID",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Maint: maintenance; ID: insufficient data; NR: not recommended.",
"     <br>",
"      * Doses shown are total grams per day and must be divided in 3 or 4 equally divided doses for certain formulations. For details, see Lexi-Comp drug information included with UpToDate and the official prescribing information.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       Various formulations with differing release characteristics are available and vary by country. Trade names shown may be specific to US. Mesalazine is the international nonproprietary name for mesalamine.",
"       <br>",
"        &Delta; 2-4 grams per day in 3 or 4 equally divided doses used in practice.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22733=[""].join("\n");
var outline_f22_12_22733=null;
var title_f22_12_22734="Atrial flutter stroke risk";
var content_f22_12_22734=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F67382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F67382&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 520px\">",
"   <div class=\"ttl\">",
"    Stroke risk in atrial flutter is related to concomitant atrial fibrillation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 500px; height: 323px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Among 395,147 patients over 65 years of age, the risk of stroke in those with chronic atrial flutter is increased when atrial fibrillation (AF) is also present and is equivalent to the risk associated with only AF. The incidence of stroke in those with isolated atrial flutter is the same as the risk in the control patients who have no atrial arrhythmia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Biblo LA, Yuan Z, Quan KJ, et al. Am J Cardiol 2001; 87:346.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22734=[""].join("\n");
var outline_f22_12_22734=null;
var title_f22_12_22735="Nexplanon";
var content_f22_12_22735=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F75912&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F75912&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nexplanon",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Applicator design elements:",
"    <br/>",
"    <ul>",
"     <li>",
"      Cap-blocking mechanism with cap/lever",
"     </li>",
"     <li>",
"      Implant retained in needle before insertion",
"     </li>",
"     <li>",
"      Single-handed movement with slider",
"     </li>",
"     <li>",
"      Self-explaining actions",
"     </li>",
"     <li>",
"      Needle partly visible",
"     </li>",
"    </ul>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission of MSD Oss B.V., a subsidiary of Merck &amp; Co., Inc., Whitehouse Station, New Jersey, USA. All rights reserved. NEXPLANON is a registered trademark of MSD Oss B.V. All requests to reproduce this copyrighted material should be directed to MSD Oss B.V.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_12_22735=[""].join("\n");
var outline_f22_12_22735=null;
